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ABSTRACT PAGE
We report formation of 2-pyridones from 2,5-diketopiperazines by first accessing 
a [2.2.2]-diazabicyclic structure formed from a domino sequence involving aldol 
condensation, alkene isomerization, and hetero-Diels-Alder cycloaddition. 
Conditions to produce the cycloreversion were optimized to reveal the desired 
pyridone functionality. The reaction pathway has been investigated with different 
diketopiperazines, aldehydes, and alkynal components, involving both inter and 
intramolecular cycloaddition templates. These efforts were directed toward the 
synthesis of louisianin B completed in 10 steps with 1.5% yield.
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Chapter 1
Synthetic Approaches Towards Constructing 2-Pyridones
Introduction
2-Pyrid6nes are a common structural moiety found in several biologically active 
molecules. Recently, an increased interest in this class of compounds has emerged due to 
their wide array of properties, ranging from pharmacological to agrochemical activities.1 
2-pyridones are 6-membered heterocyclic aromatic alkaloid motifs; however, other 
pyridone isomers exist, such as 4-pyridones. Below in Figure 1.1 is a common 
numbering system for pyridone scaffolds, along with the pyridone and hydroxypyridine 
tautomers.
2°  OH 
3 f i ^ N H  ^  r f ^ N
5
2-Pyridones 4-Pyridones
Figure 1.1 Structure and tautomeric forms of 2-pyridones and 4-pyridones
The stability of the 2-pyridone compared to the 2-hydroxypyridine has been 
debated for many years. It was found that only in very dilute nonpolar solvents or in the 
gas phase is the hydroxypyridine be favored. In more concentrated solutions, the 
pyridone form is stabilized by forming a dimer through hydrogen bonding interactions. In 
aqueous solutions, 2-pyridone tautomers are found to be 1000:1 times more stable than
1
their hydroxypyridine counterparts.2
3-hydroxypyridines, a common scaffold of some bioactive molecules such as 
vitamin B6, can exhibit zwitterionic properties through a proton transfer from the 
hydroxyl group to the nitrogen in the ring system. They possess a dominant phenolic 
character that is caused by their inability to form the energetically favorable keto 
tautomers that are present in 2- and 4-pyridones.3
Possessing a wide variety of pharmacological and agrochemical properties, 
pyridones and their analogues have exhibited characteristics of DNA gyrase inhibitors, 
reverse transcriptase inhibitors for HIV-1, and my cotoxins. In 1864, the first pyridone 
alkaloid to be isolated was ricine, a poisonous crystalline substance found in castor beans. 
The structure was unknown at the time and not elucidated until 1904 by Maquenne and 
Philippe.4 Camptothecin, a 2-pyridone isolated in 1966 from the tree Camptotheca 
acuminata in China, was found to be a topoisomerase inhibitor, a characteristic of several 
anticancer drugs. Because of its biological activity, camptothecin has become a common 
synthetic target. However, in the 1980’s, camptothecin failed clinical trials due to 
insolubility in the human body and toxicity. Derivatives of camptothecin have been 
approved by the FDA for the treatment of patients with ovarian, small-cell lung, and 
colorectal cancers.5 Huperzine A has recently been studied as a molecule of interest due 
to its potent reversible inhibition of acetylcolinesterase. For this reason, huperzine A has 
been viewed as a possible treatment of Alzheimer’s disease to improve the cognitive 
function.1 Aristopyridinone A was isolated in 2011 from Aristolochia, a traditional 
Chinese medicinal plant that possesses antibacterial, anti-inflammatory, and anti­
2
asthmatic properties.6 Most recently in 2013, four new 4-hydroxy-2-pyridones were 
isolated by Koyama from a fungus, Stagonosporopsis cucurbitacearum. One of the 
pyridones, didymellamide A, was shown to exhibit antifungal character against azole- 
resistant C. albicans? The structures of these natural products are shown in Figure 1.2 
below.
OMe
^ iA o
Me
Ricine 
Isolated: 1864 
Total Synthesis: 1923
Me OH O
(+)-Camptothecin 
Isolated: 1966
Huperzine A 
Isolated: 1994
(+)-Aristopyridinone A 
Isolated: 2011
Didymellamide A 
Isolated: 2013
Figure 1.2 Isolated alkaloid natural products possessing a pyridone moiety
Synthetic Methods Toward Pyridones
2-Pyridones have been accessed using two main strategies: functionalizing a
pyridine core or constructing the heterocyclic ring through various types of reactions,
including condensations, organometallics catalyzed [2+2+2] cyclizations, and
cycloadditions. Oxidation of pyridines has been shown in several examples to be a facile
route toward the formation of 2-pyridones (eq 1) (Scheme 1.1). Potassium ferricyanide
can oxidize pyridines with high yields. Pyridones have also been constructed
3
through the hydrolysis of a-halopyridines, (eq 2) (Scheme 1.1).1
M e s y ^ . M e  1) Me2S04, 110 C 
2) NaOH, K3Fe(CN)6
Me
(1)
N
Ar\ ^ ^ A r  1,4 Dioxane/HgO^Ai v ^ ^  Ar________________________(2)
IST^F ISf^OH h °
92%
Scheme 1.1 Oxidative methods for the synthesis of 2-pyridones
Since condensations are believed to be the mechanism through which 2-pyridone 
derivatives, such as 4-hydroxy-2-pyridones, are constructed biologically, many groups 
have utilized this type of reaction to form the desired pyridone core structure. Pyrones 
have been converted into pyridones using a condensation reaction.8 Pyrone 1 was treated 
with ammonia, causing addition into the carbonyl, opening to intermediate 2 (Scheme 
1.2). The nitrogen of the newly formed amide could then attack the aldehyde, closing the 
ring system to form the desired pyridone 3.
NH3 NH3, dioxane
O
O l 2075y 2h > ( f j j NH
1 3
A
c?vn+h3 1 X
i ^ n h ,  _ fi r  ]2C ?  [f n h 2 h c
Scheme 1.2 Conversion of pyrone to pyridone
4
In 2000, Camps synthesized the acetylcolinesterase inhibitor huperzine A through 
a condensation reaction (Scheme 1.3).9 The [3.3.1] bicycle of the natural product was 
initially constructed, which required the pyridone moiety to be subsequently appended. 
The condensation of pyrrolidine with the ketone of bicyclic structure 4 afforded an 
enamine that could undergo a conjugate addition with propiolamide. Hydrolysis of the 
pyrrolidine reveals the ketone, allowing for condensation with the pendant amide, 
cyclizing and forming the desired 2-pyridone. While the conjugate addition was not 
appreciably regioselective, the 2-pyridone of huperzine A was synthesized by Camps 
with 40% yield, and the regioisomer, 5, was produced with 26% yield.
Me Me
26%
NHMe NH
NHCOoMe NH
Me MeNHCOoMe
NH.
40%
NHR NH
,0  1) pyrrolidine,
benzene 80 °C
Huperzine A
Scheme 1.3 Pyridone formation in Camps synthesis of huperzine A
Organometallic reagents have been heavily used to synthesize 2-pyridones, a 
summary of/ which is shown in Table 1.1. Yamazaki, in 1977, utilized methyl 
phenylpropiolate and methyl isocyanate along with a cobalt catalyst in their efforts to 
facilitate [2+2+2] cycloadditions, a general scheme of which is shown in Figure 1.3.10
5
u *cin" NR [2+2+2] >
Figure 1.3 General [2+2+2] cycloaddition
In 1982, Hoberg used a nickel catalyst with both symmetric and asymmetric alkynes and 
isocyanates to form pyridones in a partially regioselective manner. Vollhardt, in 1984, 
utilized a cobalt catalyst to enable a pseudo intermolecular cycloaddition between a 
tethered alkyne and isocyanate pair and a second alkyne.11 The purpose of tethering was 
to limit regioisomers that would be formed through the cyclization reactions that had 
been noted with previous organometallic reactions. Itoh, in 2005, looked to use the first
ruthenium catalysts for pyridone synthesis, using a similar tethering approach with 1,6-
1 ^
diynes and isocyanates. In 2009, Rovis was able to access both 2-pyridones and 4- 
pyridones using a rhodium catalyst in a regioselective intermolecular [2+2+2]
o
cycloaddition. More recently, Takeuchi, in 2012, looked to use iridium as a catalyst
1 ^when tethering two alkynes together and varying the substituents on the isocyanate. 
Kondo, in 2006, expanded on previous rhodium catalysis to achieve selectivity between 
the formation of pyridones and pyrimidines using isocyanates and symmetric alkynes.14 
The proposed catalytic cycles for these transformations are shown in Figure 1.4.
6
Author, Year Metal Catalyst Starting Material Pyridone Scaffold
Hoberg,
1982 Ni(COD)2 PCy3
2R1 — R2 
RN=C=0
O
R2 v A  Ri Ri = Ph, Et, Me, H 
|  ? R2 = Ph, Et, Me, H
R s T  Rs R3 = Ph, 
r 2
Vollhardt,
1984 CpCo(CO)2
X Ri
II
X—N=C:0
r2
x x  X = H, A n
\ n J L \ m 1  R = TMS, Me, f-Bu 
Y ^ Rl V N  Y ^ R  R, = TMS, Et, C 02Et
o  o
Itoh,
2005 CpRu(COD)CI
x' -=■ Me 
'— = — Me
RN:C:0
^ M R  X = -C(C02Me)2 -O
yT\  i -c  -NTs
R = Bn, Ph, Cyclohexane, Furan
Kondo,
2006 RhCI(PPh3)2,
2Et—= —Et 
RN=C-0
O o  R=Bn 
u Et ji cyclohexane, 
RN RN NR furan, Ph 
b A A e  e  R = Ph, P-tolyl,
1=1 | 1=11=1 | ^  n-hex, cyclohexyl, 
Et Et p- CIC6H4
Rovis,
2009 [Rh(C2H4)2CI]2
Ri~=
r 2n=c=o
O Q R i = p-MeO-C6H4 
Jl A  R 2  = Bn, PMB, Ph,
X t2rXXr ^ h ex ' c y
R i ^ r A i  r 2 Rt
Takeuchi,
2012
[lr(COD)CI]2
(R)-Hg-BINAP
Me02C ^ _  —  Me 
Me02C —  Rl
r 2n--c=o
Me
M e02C ^ /— | ^ R 2 R1 = Ph’ ™ s > C 02Me 
Me02C v A sA q  R2 = Bu, p-MeO-C6H4
R1
Table 1.1 Summary of organometallic catalysts for pyridone synthesis
7
Ri—E=— R1 R2-N = c = 0
Figure 1.4 Proposed catalytic cycle for metal-catalyzed [2+2+2] cycloadditions
In 2002, Takahashi’s work led to a highly regioselective 2-pyridone synthesis 
using stoichiometric amounts of both zirconium and nickel.15 Zirconium initially forms 
metallocycle 6 after reaction with an alkyne and isocyanate (Scheme 1.4). This is 
followed by transmetallation to form the nickel metallocycle 7, after which regioselective 
insertion of a second alkyne occurs. Takahashi was able to produce a single regioisomer 
8 with relatively high yields for each reaction by selective addition of the alkynes and 
isocyanates.
8
CpoZrEto — ~ ~ — — 4  
K2 2 -78 to 0 °C
6
v
Ph
R1 R2 R3 R4
Ph Ph Ph Ph
Ph Ph Me Ph
Me Ph Ph Ph Ph
Rc
Re
50 C O N R4
Ph
8
Scheme 1.4 Takahashi’s proposed mechanism for cyclometallation and pyridone 
formation
Other organometallic reactions have been utilized to form 2-pyridones, including 
the palladium-catalyzed Stille reaction and the zinc-catalyzed Blaise tandem reaction.16,17 
Choice of both metal and ligand can greatly impact the ability of transition metal 
mediated cyclization to form these alkaloid structures, and for this reason, many authors 
screen various metal and ligand combinations. Several of the abovementioned catalysts 
were incompatible with terminal alkynes; however, Tanaka, in 2005, reported the use of
1 o
terminal alkynes to synthesize various pyridones with chiral rhodium catalysts. These 
are some of the examples of reactions that have been utilized to achieve the construction 
of 2-pyridone skeletons.
9
Cycloadditions and Cycloreversions to Produce 2-Pyridones
Cycloadditions and cycloreversions have been used to construct several types of
1 A AA A1
aromatic systems, includmg pyrimidines, pyridines, and pyridones. Cycloadditions 
are characterized by the interactions of two n systems from the diene and the dienophile. 
Thermal conditions allow the pericyclic donation of electrons from HOMO of the diene 
into the LUMO of the dienophile (Figure 1.5).
HOMO
LUMO
HOMO
LUMOSH
Constructive Destructive HOMO-LUMO Interactions
Orbital Overlap Orbital Overlap f°r an Endo Diels Alder
Figure 1.5 Orbital representation of a [4+2] cycloaddition
Diels-Alder cyclizations, [4t z  + 2n] cycloadditions, conventionally occur with an 
electron rich diene and electron poor dienophile. Manipulations of the diene and 
dienophile by the addition of electron donating and electron withdrawing substituents, 
respectively, can help facilitate cycloadditions. Constructive overlap of the involved n 
orbitals is required for the cycloaddition to proceed. Cycloreversions, or retro-Diels- 
Alder reactions, are the reverse of cycloadditions, generating two separate n systems.
Cycloadditions of heterocyclic systems with a dienophile form bicyclic 
intermediates, which are often able to undergo a cycloreversion. In many of these cases, 
however, the bicyclic intermediate is not thermally stable and cannot be isolated due to 
the temperatures required to drive the cycloaddition. For a cycloreversion of a
10
bicyclic cycloadduct to occur, one bridge must be lost, although there are several
22 1 possibilities for the specific byproduct formed. Diatomic nitrogen, carbon dioxide,
hydrogen cyanide,20 and acetonitrile are some of the compounds that are commonly used
as the cleaved bridge for the cycloreversion. Some examples of dienes and the
corresponding leaving bridge include oxazoles, where water is subsequently lost as a
byproduct of the cycloreversion, and monotriazines, in which diatomic nitrogen is
expelled.23 Oxazinones, for example, have been used because when the cycloreversion
occurs, carbon dioxide is produced. Cycloadditions of oxazinones followed by
cycloreversions have often been used to form pyridines; however Shioiri was able to
form pyridones such as 9 using oxazinones (Scheme 1.5).24
COoMe TMSO
TMSO 1 8 0 -1 9 5  °C
COpMe
R = Ph, Bn, p-N02C6H4,
1 )-C 02
2) H20  
-TMSOH
X
J \ X 0 2Me
C T ^ N  R 
H
X = X, C 0 2Me
Scheme 1.5 Use of oxazinone to form 2-pyridones
In 1972, Sammes worked on using pyrazines to* form pyridones through a Diels- 
Alder cycloaddition followed by cycloreversion (Scheme 1.6). Using pyrazme 10, 
heating to 100 °C for 30 minutes provided direct formation of two regioisomeric 2- 
pyridones, 11 and 12, through loss of isocyanic acid. Symmetric pyrazine 13 was used to 
show that loss of isocyanic acid from cleavage of either bridge would produce the same 
pyridone, 14, and not result in a mix of regioisomers.
11
Scheme 1.6 Utilization of pyrazines to form pyridones
N-Alkyl pyrazinones were also investigated to exemplify the breadth of substrates 
that could be accessed (Scheme 1.7). However, with a protected nitrogen species, such as 
lactim o-ethyl ether 15, the desired cycloreversion product 16 was not observed, even 
when the cycloadduct was heated to 200 °C. The authors instead used hydrochloric acid 
hydrolysis of the dimethyl acetylenedicarboxylate (DMAD) cycloadduct to access 
triester-substituted pyridones.
CQ2Me
EtO N Me DMAD r.
Me
15
O
HCI
Me
16
Scheme 1.7 Conversion of blocked pyrazinones to pyridones
Sammes, in 1978, furthered his previous work to construct
dihydropyridones, which could then be oxidized to the desired pyridone structures 
(Scheme 1.8).26 The intramolecular cycloaddition between a dihydroxypyrimidine core 
and a pentene side chain of 17 required a temperature of 198 °C for 6 hours in DMF to 
produce the desired bicycle 18. The cycloreversion then occurred through cleavage of 
either lactam bridge, resulting in the loss of isocyanic acid once heated to 200 °C for a 
prolonged number of hours, forming the desired dihydropyridone 19. Direct access of the 
dihydropyridone was possible in one step if the starting pyrimidine was heated to 200 °C 
for an extended period of time.
198 °C, 6 h  
DMF HN“^ N  
Me H
18
200 °C
O
Xylenes
Scheme 1.8 Formation of pyridones from dihydropyrimidines
The use of the alkene side chains required a later oxidation by heating in xylenes over a 
palladium-carbon catalyst to access the desired pyridone core 20. To assess the 
applicability of the reaction, Sammes looked at using a hexene side chain to act as the 
dienophile. Extended reaction times were required for the longer chain length substituent. 
Sammes extended his work by synthesizing actinidine, 21, using an intramolecular 
cycloaddition,21 but this time using an alkyne side chain. This set up for subsequent
13
cycloreversion to form the aromatic system through loss of isocyanic acid (Scheme 1.9). 
Direct access of the 2-pyridone was achieved by using an alkyne; however, Sammes 
desired a pyridine in the final product.
Me MeMe Me Me198 °CHO.
HNDMF
NH
Me
actinidine 21
Me
Scheme 1.9 Sammes synthesis of actinidine
Formation of pyridones through cycloadditions does not always require a 
cycloreversion as had been utilized in the above examples. In 1981, Ghosez utilized a 
Diels-Alder cycloaddition to form 2-pyridones.27 Acetylacetamide and formylacetamide 
were converted into the necessary imides by using tert-butyldimethylsilyl triflate to form 
silylated ether azadiene, 22. These could then be allowed to react with DMAD refluxing 
in chloroform to form the desired pyridone 23 after hydrolysis with HC1 (Scheme 1.10). 
Formylacetamide was combined with methyl propiolate to form pyridone 24 
regioselectively once refluxed in benzene for 14 hours followed by hydrolysis.
14
TBSO T B S 0 ^ /v Ns^ C 0 2Me |_jq|
"X^OCfeMe “  HNt*S
Y *  DMAD
Nv - RJ  COgM
OTBS TBSO R
'CC)2Me
22
R
23
R = H, Me
TBSO
Y ^  '>H‘ =— C 0 2Me ° Y ^ ]
NY H ii)~HCI **
OTBS 24
C 0 2Me
Scheme 1.10 Accessibility of pyridones using a Diels-Alder cycloaddition
Pyridines have also been synthesized using a cycloaddition followed by a 
cycloreversion. Sammes showed that this could be achieved using pyrimidine 25 and a 
pentene side chain that could undergo a cycloaddition. Heating the pyrimidine at 198 °C 
for 18 hours led to direct access of pyridine 27 (Scheme 1.11). The intermediate bicycle 
26 was isolated when heated to 145 °C.
198 °C Me
DMF
26
-HNCO
O
Me‘ Me
27
Scheme 1.11 Construction of pyridines from dimethylpyrimidines
Loss of either isocyanic acid or acetonitrile was possible with the bicyclic intermediate;
however, Sammes observed only loss of isocyanic acid. Even with these two competitive
cycloreversions, the cleavage of isocyanic acid was seen to be most favorable. Following
the cycloreversion, aerial dehydrogenation produced the desired aromaticity, not
15
requiring the authors to perform a subsequent oxidation step.
In 1989, van der Plas looked at steric and electronic effects for inverse electron 
demand Diels-Alder reactions. It was proposed that steric hindrance more greatly 
impacted the reaction rate than did electronic effects. Furthermore, the authors examined 
six different substrates and suggested that cycloadducts were formed as intermediates; 
however, they were not isolated. Instead, they were thought to undergo spontaneous 
cycloreversion to form pyridines when heated to 180 °C, a similar finding to Sammes’ 
work from 1977. Several other cases reported that the intermediate cycloadduct could 
not be isolated, and instead, a cycloaddition followed by cycloreversion occurred in one 
process. In this work, van der Plas focused on substituent effects on the cycloaddition but 
also demonstrated that even though the substituents were varied, the cycloreversions in 
all six cases occurred spontaneously following the cycloaddition (Scheme 1.12).
NC CN
R = H, Br, Cl, Me, OMe, NO;
NC CN
NC-
NC
Scheme 1.12 Cycloaddition and spontaneous cycloreversion to form pyridines
16
Constructing 2-pyridones through cycloadditions and cycloreversions has been 
studied for many years. Many of these reactions require high temperatures and several 
hours to form desired pyridones through a bicyclic intermediate. Heating some of the 
compounds proved to be futile, since even temperatures up to 200 °C could not produce 
decomposition of the bicycle into the desired pyridone. However, many authors noted 
that the intermediate bicycle could not be isolated and, instead, at high temperatures 
directly accessed the 2-pyridones.
17
W orks C ited
1. Torres, M.; Gil, S.; Parra, M. New Synthetic Methods to 2-Pyridone Rings. Current 
Organic Chemistry, 2005, 9, 1757-1779.
2. Miller, B.; Advanced Organic Chemistry: Reactions and Mechanisms; Challice, J.:
New Jersey, 2004; 329-330.
3. Lu, J.; Arndt, H. Hetero Diels-Alder Synthesis of 3-Hydroxypyridines: Access to the 
Nosiheptide Core. J. Org. Chem., 2007, 72, 4205-4212.
4. Jessen, H. J.; Gademann, K. 4-Hydroxy-2-pyridone Alkaloids: Structures and synthetic 
approaches. Nat. Prod. Rep., 2010, 27, 1168-1185.
5. Du, W. Towards new anticancer drugs: a decade of advances in synthesis of 
camptothecins and related alkaloids. Tetrahedron, 2003, 59, 8649-8687.
6 . Chung, Y.; Chang, F.; Tseng, T.; Hwang, T.; Chen, L.; Wu, S.; Lee, C.; Lin, Z.; 
Chuang, L.; Su, J.; Wu, Y. A novel alkaloid, aristopyridinone A and anti-inflammatory 
phenanthrenes isolated from Aristolochia manshuriensis. Bioorg. Med. Chem. Lett., 2011, 
21, 1792-1794.
7. Haga, A.; Tamoto, H.; Ishino, M.; Kimura, E.; Sugita, T.; Kinoshita, K.; Takahashi,
K.; Shiro, M.; Koyama, K. Pyridone Alkaloids from Marine-Derived Fungus, 
Stagonosporopsis cucurbitacearum, and Their Activities against Azole-Resistant 
Candida albicans. J. Nat. Prod., 2013, 76, 750-754.
8 . Shojaei, H.; Bohmer, Z.; von Zezschwitz, P. Iromycins: A New Family of Pyridone 
Metabolites from Streptomyces sp. II. Convergent Total Synthesis. J. Org. Chem. 2007, 
72, 5091-5097.
9. Camps, P.; Conteras, J.; Achab, R. E.;Morral, J.;Munos-Torrero, D.; Font-Bardia, M.; 
Solans, X.; Badia, A.; Vivas, N. M. New Syntheses of rac-Huperzine A and its rac-1- 
Ethy 1-Derivative. Evaluation of Several Huperzine A Analogues as Acetylcholinesterase 
Inhibitors. Tet., 2004, 56, 4541-4553.
10. Oberg, K. M.; Lee, E. E.; Rovis, T. Regioselective Rhodium-Catalyzed 
intermolecular [2+2+2] Cycloaddition of Alkynes and Isocyanates to Form Pyridones.
Tet., 2009, 65, 5056-5061.
11. Earl, R. A.; Vollhardt, P. C. Cobalt-catalyzed cocyclizations of isocyanato alkynes: a 
regiocontrolled entry into 5-indolizinones. Applications to the total synthesis of 
camptothecin. J. Am. Chem. Soc. 1983,105, 6991-6993.
18
12. Yamamoto, Y.; Takagishi, H.; Itoh, K. Ruthenium(II)-Catalyzed Cycloaddition of
1.6-Diynes with isocyanates Leading to Bicyclic Pyridones. Org. Lett. 2001,13, 2117- 
2119.
13. Onodera, G.; Suto, M.; Takeuchi, R. Iridium-Catalyzed [2+2+2] Cycloaddition of 
a,co-Diynes with Isocyanates. J. Org. Chem. 2012, 77, 908-920.
14. Kondo, T.; Nomura, M.; Ura, Y.; Wada, K.; Mitsudo, T. Selective synthesis of 2- 
pyridones and pyrimidines-2,4-diones by neutral rhodium(I) complex-catalyzed 
cyclotrimerization of alkynes and isocyanates. Tet. Lett., 2006, 47, 7107-7111.
15. Takahashi, T.; Tsai, F.; Li, Y.; Wang, H.; Kondo, Y.; Yamanaka, M.; Nakajima, K.; 
Kotora, M. Selective Preparation of Pyridines, Pyridones, and Iminopyridines from Two 
Different Alkynes via Azazirconacycles. J. Am. Chem. Soc., 2002,124, 5059-5067.
16. Cherry, K.; Abarbri, M.; Parrain, J.; Duchene, A. Regio- and selective synthesis of
4.6-disubstituted-2-pyridones. Tet. Lett., 2003, 44, 5791-5794.
17. Chun, Y.; Ryu, K. Y.; Ko, Y. O.; Hong, J. Y.; Hong, J.; Shin, H.; Lee, S. One-Pot 
Synthesis of 2-Pyridones via Chemo-and Regioselective Tandem Blaise Reaction of 
Nitriles with Propiolates. J. Org. Chem., 2009, 74, 7556-7558.
18. Tanaka, K.; Wada, A.; Noguchi, K. Rhodium-Catalyzed Chemo-, Regio-, and 
Enantioselective [2+2+2] Cycloaddition of Alkynes with Isocyanates. Org. Lett., 2005, 7, 
4737-4739.
19. Boger, D. L.; Dang, Q. Inverse Electron Demand Diels-Alder Reactions of the 2,4,6- 
Tris(ethoxycarbonyl)-l,3,5-triazine and 2,4,6-Tris(methylthio)-l,3,5-triazine: Pyrimidine 
Introduction. Tet., 1987, 44, 3379-3390.
20. Frissen, A. E., Marcelis, A. T. M.; van der Plas, H. C. Ring-Transformations of 
Pyrimidines by Intramolecular Diels-Alder Reactions. Synthesis of Annelated Pyridines. 
Tet. 1988, 45, 803-812.
21. Davies, L. B.; Greenberg, S. G.; Sammes, P. G. Synthesis of (±)-Actinidine by an 
Intramolecular Cycloaddition Process. J. C. S. Perkin 1 ,1981, 1909-1911.
22. Rickbom, B. (1998). The Retro-Diels-Alder Reaction. Part II. Dienophiles with One 
or More Heteroatom. In L. A. Paquette. (Ed.), Organic Reactions (223-631). New York: 
John Wiley & Sons, Inc.
23. Boger, D. L.; Diels-Alder Reactions of Heterocyclic Azadienes: Scope and 
Applications. Chem. Rev. 1986, 86, 781-793.
24. Shioiri, T.; Takaoka, K.; Aoyama, T. ^^Silylketenes as a Useful Building Block for
Heterocycles. J. Hetero. Chem., 1999, 36, 1555-1563.
25. Machin, P. J.; Porter, A. E. A.; Sammes, P. G. Pyrazine Chemistry. Part V. Diels- 
Alder Reactions of Some 2,5-Dihydroxypyrazines. J. C. S. Perkin 1 ,1973, 404-409.
26. Davies, L. B.; Leci, O. A.; Sammes, P. G. Intramolecular Cycloaddition Reactions of 
Mono- and Di-hydroxypyrimidines. J. C. S. Perkin 1 ,1978, 1293-1297.
27. Sainte, F.; Serckx-Poncin, B.; Hesbain-Frisque, A.; Ghosez, L. A Diels-Alder Route 
to Pyridone and Piperidone Derivatives. J. Am. Chem. Soc. 1982, 5, 1428-1430.
28. Frissen, A. E.; Marcelis, A. T. M.; Melger, W. C.; van der Plas, H. C. Substituent 
Effects in the Intramolecular Inverse Electron Demand Diels-Alder Reactions of the 5-(p- 
Substituted Phenyl)-2-(l,l-Dicyanopent-4-yn-l-yl)pyrimidines. Tet. 1989,45, 6891- 
6900.
20
Chapter 2
Methodological Approaches Toward 2-Pyridones
Previous Cycloreversions to Produce 2-Pyridones
Sammes, in 1973, demonstrated how a 2,5-dihydroxypyrazine diene, such as 1, 
could undergo a cycloaddition with a dienophile, dimethyl acetylenedicarboxylate 
(DMAD) (Scheme 2.1).1 When heated to 100 °C for 30 minutes, both the cycloaddition 
and cycloreversion occurred, forming a 1:1 mixture of regioisomers, pyridones 3 and 4. 
The bicyclic intermediate 2 was not isolated. Cycloadditions with A-alkyl pyrazinones 
were also explored with DMAD as the dienophile. Cycloadduct 5 formed at room 
temperature and was then heated to 200 °C to drive the cycloreversion; however, this was 
not a sufficient set of conditions to form the desired pyridone 6 .
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Scheme 2.1 Sammes’ work on cycloreversions to 2-pyridones
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Development of Cycloaddition Conditions Towards [2.2.2]-Diazabicycles
The class of molecules containing a [2.2.2]-diazabicyclic structure has members 
including malbrancheamides, brevianamides, and stephacidins and possesses a wide 
variety of biological activities. Previous works in the Scheerer lab have demonstrated 
how [2.2.2]-diazabicycles can be constructed using a diketopiperazine (DKP) diene in an 
intermolecular Diels-Alder cycloaddition (Scheme 2.2). The intermolecular 
cycloadducts 7 and 8 with the lactim ether bridge proved to be stable in toluene to a 
temperature of 110 °C for 16 hours, similarly to Sammes’ work with a lactim ethyl ether 
bridged cycloadduct. However, one intermolecular cycloadduct, 9, underwent 50% 
conversion to 2-pyridone 10 once heated in toluene to 110 °C for 24 hours.
X J ' Bu DDQ
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MeO
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tol, 90 C N
MeO
X J ' Bur f ' N ' - A  I I H+2] II I O + II tol, 110 °C MeON
H J-Bu
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8 Ph
MeO
H / h
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Scheme 2.2 Intermolecular cycloaddition examples from Scheerer lab
We wanted to investigate intramolecular examples to see if the bicyclic structures
were stable to heating like regioisomers 7 and 8 or if they would undergo a
cycloreversion, similarly to cycloadduct 9. Beginning with a serine-derived DKP with
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a chiral phenyl aminal substituent, a one-pot domino sequence, consisting of an aldol
condensation, alkene isomerization, and intramolecular Diels-Alder cyclization, could be
\
used to access the desired [2.2.2]-bicyclic core (Scheme 2.3).
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Scheme 2.3 Domino reaction sequence to access [2.2.2]-diazabicycles
Two sets of conditions were optimized so that we could study enolizable and non- 
enolizable aldehydes in the construction of eight different [2 .2 .2]-diazabicycles with good 
diastereoselectivity;4 a selection of examples is shown in Scheme 2.4. With 
nonenolizable aldehydes, it was possible to employ conditions of sodium methoxide in 
methanol followed by heating the reaction to 65 °C. However, this cannot be exploited 
with enolizable aldehydes due to potential undesired aldol products. To circumvent this, 
we envisioned a stepwise one-pot scheme accessing similar intermediates.
First, LiHMDS was used to form the DKP enolate, which is followed by
subsequent aldol addition into the aldehyde. The derived metal alkoxide is
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acetylated with acetic anhydride, facilitating elimination. Treatment with DBU both 
effects acetyl elimination to 11 and alkene isomerization to the azadiene 12. Upon 
heating, the cycloaddition is observed with the pendant alkene or alkyne dienophile.
Nonenolizable Aldehydes (Condition A)
O 1
H Ph
MeO
Enolizable Aldehydes (Condition B)
MeO
N
IN O 
\ /
68%
(>95:5)
H Ph
CHO o  'A
40% 
i j j  (>95:5)
13
Condition A: a) DKP (1 equiv.), ArCHO (2 equiv.) at 0 .1 5 -0 .2  M in 
MeOH.NaOMe (3 equiv.), 65 °C  1 6 - 2 4  h; Condition B: a) DKP 
(1 equiv.), LiHMDS (1.1 equiv.), - 7 8  °C; b) RCHO (1.2 equiv.), - 7 8  °C; 
c) Ac20  (1.3 equiv.) - 7 8  °C to rt; d) DBU (2 equiv.) rt to 90 °C, 16 h.
Scheme 2.4 Examples of [2.2.2]-diazabicyclic structures
One intramolecular example demonstrated use of an aliphatic alkyne as the reactive 
dienophile, as seen in cycloadduct 13 (Scheme 2.4). This cycloadduct was isolable and 
the cycloreversion product was not observed by NMR. Our lab had demonstrated that the
[2 .2 .2]-diazabicycles we synthesized were generally stable to temperatures around 100 
°C; however, one example had shown conversion to a 2-pyridone through a 
cycloreversion. For this reason, we looked to see if we could optimize conditions to 
undergo a cycloreversion to form 2-pyridones.
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Diketopiperazine Syntheses
A chiral aminal substituent was necessary for our previous synthesis of the
[2 .2 .2]-diazabicyclic structures; however, with our projected route, diastereoselectivity 
was not necessary due to the lack of stereochemistry present in the pyridone scaffold. 
Two DKPs were used in these efforts, one proline derived, 14, and the other glycine 
derived, 15 (Scheme 2.5).
15
Scheme 2.5 Route towards the proline and glycine derived diketopiperazines
In both routes to the desired DKPs, the amino acid ester starting materials were acylated 
with chloroacetyl chloride. An azide displacement was then performed to set up for the 
Staudinger reduction of the azide, followed by an aza-Wittig cyclization to afford the 
proline and glycine derived DKPs in 78% and 55% yields, respectively.
The dimethoxybenzyl (DMB) protecting group was selected because it could later 
be removed to reveal a free secondary amide. Initially, a pivaldehyde-glycine derived 
DKP, 16, as well as a Boc protected DKP, 17, had been synthesized for eventual cleavage
78%,
3 Steps
14
a) Et3N, 0 °C O n OMp
55%,
3 Steps
OMe
OMe OMe
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to reveal the unprotected pyridone (Figure 2.1). The Boc DKP was shown to be unstable
domino sequence compared with the DMB DKP. The cycloadducts from the 
pivaldehyde-glycine DKP were complicated by diastereomers. We envisioned that we 
could show the versatility of our methodology if we could utilize both the glycine DKP 
as well as the sterically congested proline DKP.
Figure 2.1 Pivaldehyde and Boc protected diketopiperazines
Cycloaddition Conditions and Initial Attempts Towards Cycloreversion
We wanted to build upon the one pot domino sequence to incorporate a 
cycloreversion. We began our studies with a commerically available non-enolizable 
aldehyde, 2-ethynylbenzaldehyde, and wanted to see if our previous conditions using 
sodium methoxide in methanol could produce the desired cycloadduct. Mostly starting 
material was present along with a significantly nonpolar compound. After isolation, the 
product was determined to be l-methoxy-3-methylene-l,3-dihydroisobenzofuran, 18, 
which is thought to form through addition of the alkoxide base into the carbonyl of the 
aldehyde, followed by addition into the unsaturated alkyne to cyclize (Scheme 2.6).
when purified on silica gel, and the pivaldehyde-glycine DKP was not as efficient for the
O tBu O O
NDMBNBoc
OMe
27% yield 
over 4 steps
16
OMe
12% yield 
over 4 steps
17
OMe
55% yield 
over 3 steps
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Scheme 2.6 Dihydroisobenzofuran formation from sodium methoxide conditions
We had to approach the reaction through the more stepwise pathway using the 
enolizable aldehyde conditions determined previously. We also wanted to look at a 
substituted alkyne; therefore 2-(phenylethynyl)benzaldehyde was synthesized and also 
used in the one-pot reactions. Using the stepwise conditions provided us with a way to 
form the desired cycloadducts. We were able to isolate the bicyclic intermediates and did 
not observe cycloreversion to occur in the one pot sequence when heated in toluene to 
100 °C overnight. Since the bicycles were isolable, we wanted to see if accessing higher 
temperatures could drive the cycloreversion.
Our initial attempts involved the cycloaddition of the pivaldehyde-glycine derived 
DKP 16 and ethynylbenzaldehyde. Cycloadduct 19 was heated in toluene in a sealed tube 
at 130 °C for 17 hours, which was shown to be too mild, resulting in the isolation of the 
bicyclic starting material. The reaction was attempted again with DMF at 150 °C for 24 
hours and showed signs of formation of a methoxypyridine 20, an undesired 
cycloreversion that cleaved the bridge containing the amide (Scheme 2,7).
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i) LiHMDS
16 19 20
Scheme 2.7 Formation of methoxypyridine
Previous works required significantly higher temperatures than are possible with toluene, 
so we looked to utilize microwave technology to determine if we could pass the thermal 
threshold to cleave the desired bonds to form 2-pyridones selectively.
Previous Uses of Microwave Technology
Microwave Assisted Organic Synthesis (MAOS) was first reported to accelerate 
reaction rates when studied by Gedye and Giguere in 1986.6 The principle behind 
microwave-enhanced chemistry is that solvents or reagents can absorb the microwave 
irradiation and convert it to heat through dipolar interactions. As the electric field is 
changed, the dipoles of the reagent attempt to align with the field; consequentially, 
energy is lost in the form of heat. If there is not sufficient time for the dipoles to realign 
or if they align too quickly, no heat will be produced. Solvents are chosen based on 
physical properties, and those with small dielectric constants are preferred since they are 
microwave invisible (e.g. toluene, DCM, THF). The vessels that are used in microwaves 
are also generally microwave “invisible” and are made of borosilicate glass, quartz, or 
Teflon.
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Organic reactions are frequently run in oil baths for conductive heating, where the 
vessel and the solution closest to the walls of the container are heated the most. 
Microwaves access the dipoles of the solvent and reagent to heat the system internally, 
known as in-core volumetric heating. Microwave reactions can occur in either open or 
sealed systems. High boiling microwave active solvents have been used in open systems; 
however, in the 1990s, Strauss began work with sealed systems. This advantage allows 
for accessibility of higher temperatures from the pressurized system without requiring 
changes in volume. The solvents used can be heated well above their boiling points at 
atmospheric pressures. For example, methanol can be heated more than 100 °C above its 
boiling point when submitted to microwave conditions in a sealed tube without risk of 
explosions.3
Various reactions including transition metal couplings, carbonylations, ROMs,
f\ 7radical reactions, and rearrangements have been shown to work well in microwaves. ’ 
Cycloadditions were some of the first reaction types attempted in microwave systems. 
Dichlorobenzene and xylenes were solvents that had previously been used in some 
reactions to access temperatures to drive cycloadditions and cycloreversions. These high 
boiling solvents could prove to be problematic to separate from the product once the 
reaction was complete. Microwaves allow lower boiling solvents, such as toluene, to 
access temperatures much higher than their boiling points without the complication of 
solvent removal. With the controlled temperature and pressurized systems, we hoped to 
apply microwave technology to access our cycloreversion products.
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Cycloreversions Using Microwave Technology
Submitting cycloadduct 19 to the microwave in toluene for 1 hour with a 
maximum temperature of 248 °C, we were able to cleave the bridge containing the 
pivaldehyde-protected lactam, producing methoxypyridine 20 , the undesired 
cycloreversion product (Scheme 2.7). Similar results were seen when heated in DMF to 
form the pyridine. This demonstrated that a cycloreversion could occur, but the 
electronics of the bridges had to be manipulated to form a 2-pyridone selectively.
We anticipated that substituting a more electron-withdrawing group in place of 
the methyl ether could produce the desired cleavage. Another group such as a more 
electron withdrawing substituent could pull electron density away from the bonds 
through induction, making the C-N bond weaker and more prone to breaking. Several 
groups with more electron-withdrawing character were explored including Boc (21), 
triflate (22), and acetate (23) protection on the oxygen as well as sulfonyl (24) protection 
on the nitrogen. An electron donating substituent, a thiophenol (25), was also used to 
determine whether it could facilitate the cycloreversion. This retrosynthetic scheme is 
shown in Scheme 2.8.
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Scheme 2.8 Retrosynthesis using electron withdrawing substituents
The Boc protected cycloadduct 21 required temperatures no higher than 170 °C due to the 
thermal instability of the Boc group, leaving the lactam precursor from cleavage of the 
Boc group instead of the desired cycloreversion product. This protection did not seem 
practical because it requires at least two hours at the lower temperature so as not to cleave 
the protecting group preferentially. The acetate, triflate, sulfonyl, and thiophenol 
derivatives could withstand temperatures above 170 °C and worked well to facilitate the 
desired transformation. In practice, we selected acetate protection because it is a simple 
procedure, generally not requiring purification and instead allowing for direct submission 
to the microwave.
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Scheme 2.9 Route toward 2-pyridones
Kl, 
AcOH, 
100 °C 
99%
HN
100 °C
27
H
Using four examples of intramolecular cycloadducts that were subsequently 
acetylated, we have been able to demonstrate the microwave-assisted cycloreversions 
could be achieved (Scheme 2.9). Overall, we were able to show that our route can 
produce these 2-pyridones in a range from 31 to 60 percent yields over the course of four 
steps (Scheme 2.10).
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Scheme 2.10 Synthesized [2.2.2]-diazabicycles and corresponding 2-pyridones
Deprotection of DMB Pyridones
After constructing the pyridones, we planned to deprotect the DMB containing
oproducts. TFA has been shown to cleave a DMB protecting group, and we utilized this 
in conjunction with microwave technology to reveal the final deprotected pyridone, 38, 
for the phenyl-substituted example, 34. This was completed in a 78% yield (Scheme 
2.11). By establishing conditions for the deprotection, we were able to show the 
applicability of this route and the ability to reveal a secondary amide.
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Scheme 2.11 Deprotection of DMB pyridone
Intermolecular Examples
We have been able to demonstrate that aldol condensation, elimination, 
isomerization and intramolecular cycloaddition of diketopiperazines followed by 
cycloreversion can access 2-pyridones and wanted to extend our work to see if 
intermolecular examples could be produced. Dimethyl acetylenedicarboxylate (DMAD) 
was chosen as the dienophile and because of DMAD’s ability to act as a Michael 
acceptor,9 azadiene 39 had to be isolated first, followed by the intermolecular 
cycloaddition with DMAD.
Using the proline DKP, we were able to isolate the cycloadduct 40, in 37% yield. 
With this in hand, we wanted to see if the high temperature microwave conditions could 
reveal the desired cycloreversion with these intermolecular examples without requiring 
an electron-withdrawing substituent. Reaching a temperature of 253 °C provided 
methoxypyridine 41 with the isocyanate substituent that arose from cleavage of the 
undesired bridge (Scheme 2.12).
Attempting the same sequence of lactam formation (42) and acetylation followed 
by cycloreversion was shown to provide the desired 2-pyridone, 43, in 75% yield from 
the cycloadduct, similarly to the intramolecular cases. For this specific example, the 2-
34
pyridone was accessed both in the microwave but also when the acetylation reaction was 
heated to 140 °C, showing how the thermal barrier was significantly lowered and could 
be achieved by heating with a traditional oil bath. This is the only example we have 
encountered where the barrier to the 2-pyridone was low enough to access using thermal 
heating with an oil bath. We have since directed our attention toward accessing 
intermolecular Diels-Alder examples using the DMB DKP and examples with other 
dienophiles such as phenylacetylene, but have yet to optimize conditions to produce a 
desired intermolecular cycloadduct.
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Scheme 2.12 Intermolecular examples with formation of methoxypyridine and 2- 
pyridone
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Enolizable Aldehyde Substrates
Intramolecular cases that were previously explored only looked at non-enolizable 
aldehydes, ethynyl benzaldehyde derivatives. Two examples of enolizable aldehydes 
were used, aldehyde 44 that we planned to use on our route toward louisianin B (Figure 
2.2) and TMS protected pentynal 45 (Scheme 2.13). The former example will be 
discussed in more detail in Chapter 3 that focuses on the synthesis of louisianin B. The 
cycloaddition using the TMS protected aldehyde worked in high yield to form 
cycloadduct 46. Similar conditions to form the 2-pyridone were employed and the final 
TMS pyridone, 48, was constructed in three steps from the cycloadduct in 77% yield.
Figure 2.2 Enolizable aldehyde used toward louisianin B synthesis
NDMB
%
MeO
O
i) LiHMDS, -7 8  °C 
H) O
v n d m b
45 TMS MeO-
iii) Ac20 , -7 8  °C to rt
iv) DBU rt to 90 °C
87%
N
46
TMS
Kl, 
AcOH, 
100 °C 
88%
O
VNDMBII ^ N D M B
< Q f j DMB ^ ™ a v e  < A°2°  H N ^ ^ T M S
87% /  X  100 C
T Over 2 Steps V  >
TMS
48 47
Scheme 2.13 Enolizable aldehydes used in synthesis of 2-pyridones
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Conclusions
We were able to utilize our one-pot conditions to access several [2.2.2]- 
diazabicyclic cores using two DKPs and various alkynyl aldehydes. Thermal heating in 
an oil bath or in a sealed tube could not achieve the desired cycloreversion. Instead, we 
had to substitute an electron-withdrawing group, specifically an acetate, in place of a 
methyl ether. This allowed for more facile bond cleavage to access the desired 2- 
pyridones. Higher temperatures were also required, and for this reason we used 
microwave technology to heat the system well above the boiling point of the solvent, 
toluene. Once we accessed temperatures above 250 °C, we observed the desired 
cycloreversion to form 2-pyridones with yields ranging from 57 to 83% for the three 
steps after the formation of the bicyclic intermediate. Through this methodological work, 
we were able to use non-enolizable and enolizable aldehydes in intramolecular 
cycloadditions as well as begin to investigate intermolecular examples to form 2- 
pyridones.
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Methyl 2-(2-chloro-./V-(2,4-dim ethoxy benzyl)acetamido)acetate. Following the 
procedure from Muhuhi, Joseck et al.1 to a solution of 2-4-dimethoxybenzaldehyde (0.88 
g, 5.34 mmol) dissolved in CH2CI2 (40 mL) was added EtsN (1.10 mL, 7.96 mmol), 
glycine methyl ester hydrochloride (1.00 g, 7.96 mmol) and NaB(OAc)3H (2.20 g, 10.7 
mmol). The slurry was vigorously stirred for 24 h at rt. The reaction mixture was 
quenched with the addition of saturated aqueous NaHCC>3 and the mixture was 
transferred to a separatory funnel. The organic layer was removed and the aqueous 
portion was extracted with CH2CI2 (3 x 100 mL). The organic portions were combined, 
washed with brine, dried with sodium sulfate, filtered, and concentrated in vacuo to yield 
a clear oil (1.30 g, 5.44 mmol, 70% yield). The resulting product was used without 
purification. The oil was dissolved in CH2CI2 (15 mL) and cooled to 0 °C. To the 
solution was added chloroacetyl chloride (0.45 ml, 5.71 mmol) and Et3N (0.83 ml, 5.98 
mmol) dropwise and the reaction mixture was warmed to rt and stirred for 18 h. The 
reaction mixture was filtered through celite and the filtrate was washed with NaHC03 (3 
x 75 ml). The combined organic layers were dried with sodium sulfate, filtered, and 
concentrated in vacuo. The residue was purified by flash column chromatography on 
silica gel (elution: 25% to 85% EtOAc in hexanes) to afford the acetylated product (1.40
1 Muhuhi, Joseck; Spaller, Mark R. J. Org Chem. 2006, 71, 5515-5526.
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g, 4.44 mmol, 82% yield) as a light orange oil: TLC (40% EtOAc in hexanes), R/: 0.40 
(UV, CAM); IR (film) 3002, 2953, 2839, 2361, 1749, 1662, 1614, 1509, 1457, 1440, 
1294, 1267, 1210, 1130, 1033, 939, 835, 792, 709 cm'1; •H NMR (400 MHz, CDC13)
7.25 (d, J=  8.2, 1H), 7.03 (d, J=  8.5, 1H), 6.46 (s, 1H), 6.44-6.41 (m, 1H), 4.58 (s, 1H), 
4.52 (s, 2H), 4.35 (s, 2H), 4.11 (s, 2H), 4.03 (s, 1H), 4.02 (s, 2H), 3.80 (s, 3H), 3.77 (s, 
3H), 3.76 (s, 1H), 3.70 (s, 1H), 3.69 (s, 3H); 13C NMR (100 MHz, CDC13), 6 169.3,167.1, 
161.2, 158.7, 131.9, 130.1, 115.3, 104.2, 103.9, 98.8, 98.2, 55.4, 52.4, 52.1, 48.9, 48.2, 
46.5, 45.0, 41.3. Exact mass calcd for Ci4Hi8ClN05Na [M+Naf, 338.0768. Found 
338.0765.
DMBN ^ Cl _________,  A  NDMB
k  Nv ^C 02Me I
OMe
l-(2,4-dim ethoxybenzyl)-5-m ethoxy-l,6-dihydropyrazin-2(3//)-oiie (15). To a
solution of methyl 2-(2-chloro-Ar-(2,4-dimethoxybenzyl)acetamido)acetate (1.40 g, 4.44 
mmol) dissolved in butanone (18 mL) was added NaN3 (0.58 g, 8.89 mmol) and the 
mixture was brought to reflux with rapid stirring for 72 h. The mixture was cooled to rt, 
filtered through celite and concentrated in vacuo to yield a yellow oil (1.1 g, 3.5 mmol, 
79% yield), which was used without purification. The intermediate product was 
dissolved in toluene (28 mL) at rt and PPI13 (0.97 g, 3.68 mmol) was added. After gas 
evolution had steadied, the reaction vessel was heated to 90 °C for 19 h. The reaction 
mixture was cooled to rt and concentrated in vacuo. The resulting residue was purified by
40
flash column chromatography on silica gel (elution: 25% to 100% EtOAc in hexanes) to 
provide 15 (0.54 g, 1.94 mmol, 56% yield), a light yellow solid: TLC (60% EtOAc in 
hexanes), Rf: 0.12 (UV, CAM); IR (film) 2947, 2838, 2364, 1843, 1702, 1654, 1508, 
1325, 1292, 1244, 1210, 1034, 938, 835, 756 cm'1; 'H NMR (400 MHz, CDC13) 7.22 (d, 
J=  8.6 Hz, 1H), 6.47 (m, 1H), 6.45 (s, 1H), 4.58 (s, 2H), 4.17 (d ,./=  2.7, 2H), 3.85 (d, J  
= 2.7, 2H), 3.81 (s, 3H), 3.80 (s, 3H), 3.67 (s, 3H); 13C NMR (100 MHz, CDCI3), 5 166.3, 
161.0, 159.0, 158.4, 131.8, 116.4, 104.7, 98.6, 55.6, 53.1, 50.7, 45.9, 43.3; Exact mass 
calcd for Ci4H18N20 4Na [M+Na]+, 301.1159. Found 301.1156.
General Procedure A for aldol condensation / alkene isomerization / DKP Diels-Alder 
cycloaddition. To DMB protected diketopiperazine, 15, (1 equiv, 0.50 -  1.8 mmol) in 
toluene (0.1 M) at -78 °C was added LiHMDS (1.0M in THF, 1.2 equiv) dropwise over 5 
min by syringe. After stirring for 25 min at -78 °C the corresponding aldehyde (1.2 
equiv) was added. The solution was stirred for 15 minutes, AC2O (1.3 equiv) was added at 
-78 °C. The reaction vessel was warmed to rt, stirred for 4.5 h and DBU (2 equiv) was 
added. The reaction vessel was heated to 100 °C for 19 h, and cooled to rt. The reaction 
was quenched with saturated NH4CI (10 mL) and the aqueous phase was extracted with 
EtOAc ( 3 x 1 0  mL). The combined organic layers were washed with brine, dried with 
sodium sulfate, filtered, and concentrated in vacuo. The resulting residue was purified by 
flash column chromatography.
General procedure B for deprotection of lactim O-methyl ether. To a solution of the
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cycloadduct (1 equiv, 0.09-0.45 mmol) in AcOH (0.1-0.2 M) was added KI (3 equiv) and 
the mixture was heated at 100 °C for 2 h. The reaction was diluted with water (50 mL) 
and extracted with EtOAc (3 x 150 mL). The combined organic layers were washed with 
sodium bicarbonate (3 x 100 mL). The organic phase was washed with brine, dried with 
sodium sulfate, filtered, and concentrated in vacuo. The resulting residue was purified by 
flash column chromatography to afford the deprotected lactim ether.
General procedure C for acetylation. The lactam intermediate product (1 equiv, 0.07- 
0.15 mmol) was dissolved in a 1:1 solution of AC2O (0.5 mL) and pyridine (0.5 mL) and 
heated at 100 °C for 16 h. The reaction was cooled to rt and concentrated. The resulting 
residue was used directly in the subsequent cycloreversion reaction without purification.
General procedure D for cycloreversion to pyridone. The acylated lactam intermediate 
(1 equiv, 0.03-0.15 mmol) was dissolved in toluene and heated for 1 h-1.5 h in the 
microwave (300 W, power mode). The reaction solution was concentrated in vacuo and 
the resulting residue was purified by flash column chromatography in silica gel to afford 
the desired product.
NDMB
NDMB
OMe
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(3*S',9a5)-ll-(2,4-dimethoxybenzyl)-2-methoxy-3,9-dihydro-3,9a- 
(epiniinomethano)indeno|2,l-/>]p\ridin-10-one (29): Produced following general 
procedure A  using 15 (50 mg, 1.8 mmol). The product was purified by flash 
chromatography on silica gel (elution: 25% to 100% EtOAc in hexanes) to yield the 
purified product 29 (38 mg, 0.97 mmol, 54% yield) as a rust colored solid: TLC (60% 
EtOAc in hexanes), Rfi 0.45 (UV, CAM); IR (film) 3002, 2945, 2837, 1684, 1615, 1589, 
1507, 1466, 1334, 1306, 1266, 1210, 1160, 1036, 992, 934, 835, 756, 736 cm'1; *11 NMR 
(400 MHz, CDCls) 7.39 (d,J=  7.42 Hz, 1H), 7.30 (t, J=  8.20 Hz, 2H), 7.18 (t, J=  7.42 
Hz, 2H), 7.04 (d, J=  8.60 Hz, 1H), 6.47 (d, J=  5.47 Hz, 1H), 6.44-6.39 (m, 2H), 4.81 (d, 
J =  5.47 Hz, 1H), 4.49 (d , J=  14.85 Hz, 1H), 4.43 (d, J  = 14.45 Hz, 1H), 4.37 (d, J  = 
17.58 Hz, 1H), 3.81 (s, 3H), 3.79 (s, 3H), 3.70 (s, 3H), 3.50 (d, J  = 17.6 Hz, 1H). 13C 
NMR (100 MHz, CDC13) 8 174.7, 171.1, 160.6, 158.6, 158.5, 147.6, 133.6, 131.1, 129.9,
126.8, 126.1, 122.0, 116.7, 115.4, 104.0, 98.3, 79.0, 59.2, 55.3, 55.2, 43.7, 35.5; Exact 
mass calcd for C23H2204N2Na [M+Na]+, 413.1472. Found 413.1468.
NDMB NDMB
HN
(3£,9aA)-ll-(2,4-dimethoxybenzyI)-3,9-dihydro-3,9a-(epiminomethano)indeno[2,l- 
b]pyridine-2,10(l//)-dione (30): Produced according to general procedure B using 29 
(35 mg, 0.09 mmol). The product was obtained without purification (30 mg, 0.08 mmol,
43
89% yield) as a brown solid: TLC (5% MeOH in Chloroform), R/i 0.53 (UV, CAM); IR 
(film) 3203, 3072,2942,2841,1707, 1683, 1629,1589,1505,1466, 1303,1210,1158, 
1039, 837, 754 cm'1; lH NMR (400 MHz, CDC13) 7.56 (br s, 1H), 7.34-7.29 (m, 3H),
7.25 (m, 1H), 7.07 (d, J=  7.82 Hz, 1H), 6.55 (d, J=  5.08 Hz, 1H), 6.41 (s, 1H), 6.39 (d, J  
= 2.34 Hz, 1H), 4.61 (d, J=  14.46 Hz, 1H), 4.56 (dd, J=  5.47/1.56 Hz, 1H), 4.46 (d, J  = 
14.46 Hz, 1H) 4.21 (d, J=  18.0 Hz, 1H), 3.82 (s, 3H), 3.72 (s, 3H), 3.07 (d, J=  18.0, 1H). 
13C NMR (100 MHz, CDC13) 6 172.4, 169.5, 160.8, 158.5, 156.1, 145.8, 133.0, 131.2,
130.4, 127.5, 126.0, 122.6, 117.5, 116.1, 104.0, 98.3, 69.5, 63.4, 55.3, 55.2, 44.2, 32.8; 
Exact mass calcd for C22H2oN204Na [M+Na]+, 399.1315. Found 399.1311.
NDMB
NDMB
2-(2,4-dimethoxybenzyl)-2,9-dihydro-l//-mdeno[2,l-c]pyi'idm-l-oiie (31): Following 
general procedure C, using 30 (25 mg, 0.066 mmol) the intermediate acylated product 
was produced (19 mg, 0.047 mmol, 71% yield). This intermediate product was used (12 
mg, 0.03 mmol) to produce 31 following general procedure D. The product was purified 
by flash column chromatography on silica gel (elution: 30% to 70% EtOAc in hexanes) 
to afford the product (0.006 g, 0.018 mmol, 60% yield) as a yellow solid: TLC (60% 
EtOAc in hexanes), Rf: 0.40 (UV, KMn04); IR (film) 3067, 2962, 2839, 1700, 1507, 
1464, 1277, 1267, 1210, 1038, 927, 828, 755 cm’1; *H NMR (400 MHz, CDC13) 7.69-
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7.66 (m, 1H), 7.61-7.60 (m, 1H), 7.59 (d, J=  1.56 Hz, 1H), 7.42-7.37 (m, 2H), 6.64 (d, J  
= 7.03 Hz, 1H), 6.48-6.45 (m, 2H), 5.17 (s, 2H), 3.86 (s, 2H), 3.85 (s, 3H), 3.79 (s, 3H), 
2.05 (s, 1H). 13C NMR (100 MHz, CDC13) 5 161.1, 160.8, 158.6, 150.4, 145.2, 140.1,
137.9, 132.2, 130.9, 128.3, 126.7, 125.2, 121.1, 117.1, 104.3, 99.6, 98.5, 77.3, 55.4, 46.9,
35.6; Exact mass calcd for C2iHi9N0 3Na [M+Na]+, 356.1257. Found 356.1253.
(35,9a*S)-ll-(2,4-dimethoxybenzyl)-2-methoxy-4-phenyl-3,9-dihydro-3,9a- 
(epiniinoniethano)indeno[2,l-/)|p\ridin-10-one (32): Prepared according to general 
procedure A using 15 (100 mg, 0.36 mmol). The product was purified by flash 
chromatography on silica gel (elution: 20% to 65% EtOAc in hexanes) to afford a clear 
oil (120 mg, 0.25 mmol, 72% yield): TLC (40% EtOAc in hexanes), Rfi 0.40 (UV, 
CAM); IR (film) 3022, 3009, 2945, 2836, 1696, 1617, 1589, 1510, 1465, 1331, 1210, 
1166, 1035, 991, 835 cm-1; lU NMR (400 MHz, CDC13) 7.41 (d, J =  7.82 Hz, 1H), 7.38 
(d, J=  7.82 Hz, 1H), 7.33-7.28 (m, 3H), 7.23 (d, J=  0.78 Hz, 1H), 7.21 (d, J=  0.78 Hz, 
1H), 7.10 (d, J=  8.21 Hz, 1H), 7.08 (d, J  = 8.21 Hz, 1H), 7.08 (d, J=  7.42 Hz, 1H), 7.01 
(t, J=  7.03 Hz, 1H), 6.38 (dd, J = 8.2/2.3 Hz, 1H), 6.28 (d, J=  2.3 Hz, 1H), 5.00 (s, 1H),
4.67 (d, J=  14.5 Hz, 1H), 4.43 (d, J=  14.5 Hz, 1H), 4.41 (d, J=  17.8 Hz, 1H), 3.76 (s, 
3H), 3.75 (s, 3H), 3.58 (s, 3H); 13C NMR (100 MHz, CDC13) 5 174.8, 170.9, 160.8,
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158.4, 149.9, 147.8, 135.4, 133.8, 132.5, 131.5, 129.7, 128.4, 127.8, 127.3, 126.4, 126.0,
122.2, 116.6, 104.3, 98.3, 79.5, 64.6, 55.28, 55.27, 54.9, 43.2, 35.5; Exact mass calcd for 
C29H26N204Na [M+Na]+, 489.1785. Found 489.1777.
NDMB NDMB
PhHN
(3S,9a5)-ll-(2,4-dimethoxybenzyl)-4-phenyl-3,9-dihydro-3,9a-
(epimin<>inethano)indeno[2,l-/>|pyridine-2,10(l/y)-dione (33): Following general
procedure B, 32 (90 mg, 0.19 mmol) produced 33 without purification (88 mg, 0.188 
mmol, 99% yield) as a yellow oil: TLC (40% EtOAc in hexanes), R/: 0.18 (UV, CAM); 
IR (film) 3224, 3068, 2939, 2837, 1710, 1613, 1588, 1509, 1465, 1294, 1266, 1210, 
1159, 1036, 936, 826, 761 cm’1; lU NMR (400 MHz, CDC13) 8.38 (br s, 1H), 7.40 (d, J  = 
7.8 Hz, 1H), 7.31-7.23 (m, 3H), 7.15 (d, J=  8.2 Hz, 2H), 7.07-7.01 (m, 4H), 6.38 (dd, J  
= 8.4/2.1 Hz, 2.3, 1H), 6.24 (d, 2.3 Hz, 1H), 4.59 (d, J=  14.5 Hz, 1H), 4.79 (s, 1H),
4.45 (d, J=  14.1 Hz, 1H), 4.25 (d, J=  18.0 Hz, 1H), 3.76 (s, 3H), 3.49 (s, 3H), 3.16 (d, J  
= 11.6, 1H). 13C NMR (100 MHz, CDC13) 6 173.1, 169.3, 161.0, 158.5, 147.3, 146.0,
134.9, 134.7, 133.4, 131.7, 130.2, 128.4, 128.3, 127.3, 127.1, 126.0, 122.8, 116.2, 104.4,
98.4, 69.9, 68.9, 55.3, 54.9, 43.7, 32.9; Exact mass calcd for C28H24N204Na [M+Na]+, 
475.1628. Found 475.1625.
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2-(2,4-dimethoxybenzyl)-4-phenyl-2,9-dihydro-l//-mdeno[2,l-c]pyridm-l-one (34):
Following general procedure C, using 33 (70 mg, 0.15 mmol) the intermediate acylated 
product was produced (75 mg, 0.15 mmol, 100% yield). This intermediate product was 
used (70 mg, 0.15 mmol) to produce 34 following general procedure D. The product was 
purified by flash column chromatography on silica gel (elution: 20% to 80% EtOAc in 
hexanes) to afford the product (50 mg, 0.12 mmol, 90% yield) as a bright yellow solid: 
TLC (60% EtOAc in hexanes), R/i 0.45 (UV, CAM); IR (film) 3053, 3001, 2835, 2361, 
1648, 1612, 1590, 1505, 1457, 1430, 1377, 1287, 1266, 1207, 1158, 1125, 1034, 941, 
834, 754, 704 cm’1; *H NMR (400 MHz, CDC13) 7.57 (d, J=  7.42 Hz, 1H), 7.48-7.39 (m, 
4H), 7.32 (t, y  = 1.17 Hz, 2H), 7.26 (d, J=  2.74 Hz, 1H), 7.09 (t, J=  7.82 Hz, 2H), 6.97 
(d, J  = 7.42 Hz, 1H), 6.48 (s, 1H), 6.45 (s, 1H), 5.20 (s, 2H), 3.90 (s, 2H), 3.81 (s, 3H), 
3.78 (s, 3H). 13C NMR (100 MHz, CDC13) 6 160.8, 158.5, 148.3, 145.6, 140.1, 137.2,
136.6, 132.2, 131.3, 129.7, 128.4, 127.8, 127.8, 126.2, 124.9, 123.7, 117.6, 117.0, 104.2,
98.5, 55.32, 55.27, 55.25, 47.0, 35.7; Exact mass calcd for C27H23N 03Na [M+Na]+, 
423.1570. Found 423.1564.
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4-phenyl-2,9-dihydro-l//-indeno[2,l-c]pyridin-l-one (38): The DMB protected
pyridone, 34, (10 mg, 0.024 mmol) was dissolved in a 2:1 CH2CI2.TFA (0.9 mL) and 
heated on temp mode in the microwave to 120 °C for 10 min. The product was purified 
by flash column chromatography on silica gel (elution: 0% to 15% MeOH in CHC13) to 
afford the product (4.9 mg, 0.024 mmol, 78% yield) as a white solid: TLC (60% EtOAc 
in hexanes), Rf: 0.35 (UV, CAM); IR (film) cm 12984, 1919, 1710, 1826, 1639, 1607, 
1495, 1423, 1282, 1149, 1018, 945, 887; 'H NMR (400 MHz, CDCI3) 7.63 (d, J=  7.4 
Hz, 1H), 7.52 (m, 4H), 7.45 (m, 2H), 7.37 (t, J  = 7.4Hz, 1H), 7.29 (s, 1H), 7.13 (t, 7.6 
Hz, 1H), 6.98 (d, J  =7.815, 1H), 3.90 (s, 1H). 13C NMR (100 MHz, CDCI3) 5 161.2,
151.0, 145.0, 139.2, 135.5, 132.7, 130.4, 129.3, 128.24, 128.21, 127.8, 126.1, 124.6,
123.7, 119.6, 34.5; Exact mass calcd for Ci8Hi3NONa [M+Na]+, 282.0889. Found 
282.0891.
General Procedure -  Proline derived DKP
General Procedure E for aldol condensation / alkene isomerization / DKP Diels-Alder 
cycloaddition.To a solution of diketopiperazine 14 (1 equiv, 0.89-1.3 mmol) in toluene 
(0.1 M) at -78 °C was added LiHMDS (1 M in THF, 1.1 equiv) dropwise and the 
solution was stirred at -78 °C for 25 minutes. The corresponding aldehyde (1.2 equiv) 
was added and stirred for 15 minutes, followed by addition of AC2O (1.3 equiv). The
reaction mixture was warmed to rt and stirred for 4.5 h after which DBU (2 equiv) was 
added dropwise and the mixture was heated to 100 °C for 19 h. The reaction was 
quenched with saturated NH4CI and the aqueous phase was extracted with EtOAc (3x10 
mL). The organic layer was washed with brine (10 mL), dried with sodium sulfate, 
filtered, and concentrated in vacuo. The resulting residue was purified by flash column 
chromatography (elution: 25% to 100% EtOAc in hexanes) to afford the desired product.
General Procedure F for deprotection of lactim O-methyl ether. The cycloadduct (1 
equiv, 0.03-0.51 mmol) was dissolved in AcOH (0.05 M), KI (3 equiv) was added and 
the mixture was stirred at 100 °C for 2 h. The resulting mixture was quenched with water 
and the aqueous phase was extracted with EtOAc (3 x 150 ml) and then washed with 
sodium bicarbonate (3 x 100 ml). The organic phase was washed with brine, dried with 
sodium sulfate, filtered, and concentrated in vacuo. The product was purified by flash 
column chromatography (elution: 25% to 100% EtOAc in hexanes) to afford the desired 
product.
General Procedure G for acetylation. The lactam bridge cycloadduct (1 equiv, 0.9-0.32 
mmol) was dissolved in a 1:1 solution of AC2O (0.5 M) and pyridine (0.5 M) and stirred 
at 100 °C for 24 h. The solution was concentrated and submitted to the next step without 
purification.
General Procedure H for cycloreversion to pyridone. The protected cycloadduct (1
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equiv, 0.37-0.38 mmol), in toluene, was heated in the microwave (300 W, Power Mode) 
for 1 h. The solution was concentrated in vacuo and the resulting residue was purified by 
flash column chromatography in silica gel (elution: 40% to 100% EtOAc in hexanes, 0% 
to 20% MeOH in chloroform) to afford the desired product.
i p
OMe
12-methoxy-2,3-dihydro-l//-5a,lla-(azenometheiio)mdeiio[2,l:/lHidolizm-5(6i/)-oiie
(26): Produced following general procedure E using 14 (150 mg, 0.89 mmol). The 
product was purified by flash column chromatography on silica gel (elution: 30% to 
100% EtOAc in hexanes) to afford the product (115 mg, 0.41 mmol, 46% yield) as a 
brown oil: TLC (40% EtOAc in hexanes), R/i 0.20 (UV, KMn04); IR (film) 3269, 2984, 
2951, 2879, 1735, 1617, 1454, 1437, 1339, 1221, 1175, 1107, 1041, 1006, 841, 755 cm'1; 
'H NMR (400 MHz, CDCI3) 7.39 (d, J=  7.42 Hz, 1H), 7.34 (d, J=  7.82 Hz, 1H), 7.30 (d, 
J=  7.43 Hz, 1H), 7.20 (t, J  = 7.42 Hz, 1H), 6.45 (s, 1H), 4.32 (d ,J  = 17.6 Hz, 1H), 3.77 
(s, 3H), 3.51 (d, J=  18.0 Hz, 1H), 3.43-3.39 (m, 1H), 3.27-3.22 (m, 1H), 2.83-2.76 (m, 
1H), 2.31-2.24 (m, 1H), 2.18-2.12 (m, 1H), 2.09-2.04 (m, 1H). 13C NMR (100 MHz, 
CDCI3) 8 174.8, 169.5, 159.8, 147.5, 133.4, 129.8, 126.8, 126.0, 121.9, 119.7, 80.4, 70.4,
55.5, 42.1, 34.9, 27.0, 25.4; Exact mass calcd for CnHi6N202Na [M+Na]+, 303.1104. 
Found 303.1102.
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2,3-dihydro-l//-5a,lla-(epimmomethano)indeno[2,l:/]iiidolizme-5,12(6i/)-dioiie
(27): Produced following general procedure F using 26 (58 mg, 0.21 mmol). The product 
was obtained without purification (50 mg, 0.19 mmol, 98% yield) as a dark brown solid: 
TLC (60% EtOAc in hexanes), R/i 0.30 (UV, KMn04); IR (film) 3229, 3070, 2976, 
2942, 2879, 1691, 1465, 1393, 1326, 1260, 1195, 1156, 1086, 754, 668 cm'1; lU NMR 
(400 MHz, CDC13) 7.66 (br. s, 1H), 7.38 (d, J  = 7.82, 1H), 7.36-7.30 (m, 2H), 7.25 (m, 
1H), 6.50 (s, 2H), 4.16 (d, J =  18.0, 1H), 3.51 (m, 1H), 3.30 (m, 1H), 3.12 (d, J  = 17.6, 
1H), 2.86 (m, 1H), 2.18-2.03 (m, 2H). 13C NMR (100 MHz, CDC13) 6 173.6, 168.1,
157.4, 146.2, 133.3, 130.7, 127.9, 126.4, 122.9, 122.0, 73.0, 70.7, 43.3, 32.8, 27.3, 25.5; 
Exact mass calcd for Ci6Hi4N202Na [M+Na]+, 289.0947. Found 289.0946.
HN
2,3-dihydro-l//-indeno[2,l-/]indolizin-5(6//)-one (28): Following general procedure F,
using 27 (26 mg, 0.09 mmol) the intermediate acylated product was produced (30 mg,
100% yield). This intermediate product was used (30 mg, 0.26 mmol) to produce
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28 following general procedure H. The product was purified by flash column 
chromatography on silica gel (elution: 50% to 100% EtOAc in hexanes and 0% to 20% 
MeOH and EtOAc) to afford the product (18 mg, 0.08 mmol, 83% yield) as a dark brown 
solid: TLC (60% EtOAc in hexanes), Rf. 0.10 (UV, KMn04); IR (film) 3420, 3053, 2964, 
2896, 1657, 1570, 1457, 1295, 1296, 1241, 1152, 1096, 1019, 803, 772, 752 cm’1; !H 
NMR (400 MHz, CDC13) 7.68 (m, 1H), 7.41-7.39 (m, 2H), 7.28 (d, J =  2.74, 1H), 6.62 
(s, 1H), 4.24-4.20 (m, 2H), 3.83 (s, 2H), 3.18-3.14 (t, J=  7.23, 2H), 2.29-2.23 (m, 2H) 
13C NMR (100 MHz, CDC13) 6 160.5, 151.9, 150.7, 145.8, 140.4, 128.5,128.1, 126.9,
125.5, 121.3, 95.5, 48.6, 35.2, 32.1, 22.2; Exact mass calcd for Ci5Hi3NONa [M+Naf, 
246.0889. Found 246.0887.
O
Ph
N 
OMe
12-methoxy-ll-phenyl-2,3-dihydro-l/f-5a,lla-(azenometheno)indeno[2,l- 
J] indolizm-5(6//)-one (35): Produced following general procedure E using 14 (220 mg, 
1.3 mmol). The product was purified by flash column chromatography on silica gel 
(elution: 20% to 80% EtOAc in hexanes) to afford the product (200 mg, 0.56 mmol, 43% 
yield) as a yellow oil: TLC (40% EtOAc in hexanes), R/: 0.20 (UV, KMn04); IR (film) 
3052, 2883, 1691, 1622, 1399, 1324, 1287, 1174, 1129, 1007, 755, 743, 702 cm'1; 1H 
NMR (400 MHz, CDC13) 7.43-7.28 (m, 2H), 7.41-7.36 (m, 2H), 7.24-7.18 (m, 3H), 6.95
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(s, 2H), 4.37 (d, J=  18.0 Hz, 1H), 3.87 (s, 3H), 3.53 (d, J=  18.0 Hz, 1H), 3.48-3.46 (m, 
1H), 3.27-3.24 (m, 1H), 2.58-2.55 (m, 1H), 2.02-1.93 (m, 3H). 13C NMR (100 MHz, 
CDCls) 5 175.2, 169.9, 152.9, 147.6, 134.9, 134.0, 133.98, 132.0, 129.6, 128.7, 128.6,
128.0, 126.5, 125.9, 122.3, 79.9, 73.4, 55.9, 53.4, 42.6, 35.0, 25.5, 22.0; Exact mass calcd 
for C23H2oN202Na [M+Na]+, 379.1417. Found 379.1414.
PhHNPh
1 l-phenyl-2,3-dihydro-lH -5a9l  1 a-(epim inomethano)indeno [2,1:/] indolizine- 
5,12(6tf)-dione (36): Produced following general procedure F using 35 (431 mg, 1.2 
mmol). The product was purified by flash column chromatography on silica gel (elution: 
25% to 100% EtOAc in hexanes) to afford the product (355 mg, 1.0 mmol, 87% yield) as 
a tan solid: TLC (60% EtOAc in hexanes), Rfi 0.30 (UV, KMn04); IR (film) 3229, 3057, 
2979, 1959, 2882, 1669, 1467, 1394, 1331, 1313, 1266, 1199, 1154, 1074, 1031, 734, 704 
cm'1; lU NMR (400 MHz, CDC13) 8.32 (s, 1H), 7.26-7.37 (m, 3H), 7.32 (d, J  = 7.82 Hz, 
1H), 7.27-7.25 (m, 1H), 7.23-7.20 (m, 2H), 7.03-6.97 (m, 2H), 4.23 (d, J  = 18.0 Hz, 
1H), 3.57-3.53 (m, 1H), 3.36-3.30 (m, 1H), 3.20 (d, J =  18.4 Hz, 1H), 2.64-2.59 (m, 
1H), 1.97-1.84 (m, 3H). 13CNMR(100 MHz, CDC13) 6 173.9, 168.1, 150.2, 145.9, 136.7,
133.7, 133.5, 130.0, 128.4, 128.3, 127.2, 125.9, 123.0, 75.8, 70.2, 43.3, 32.5, 25.5, 25.2; 
Exact mass calcd for C22HigN20 2Na [M+Na]+, 365.1260. Found 365.1260.
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ll-phenyl-2,3-dihydro-lJHr-indeno[2,l-/|indolizm“5(6/0"olie (37): Following general 
procedure F, using 36 (110 mg, 0.32 mmol) the intermediate acylated product was 
produced (115 mg, 0.30 mmol, 94% yield). This intermediate product was used (115 mg, 
0.30 mmol) to produce 37 following general procedure H. The product was purified by 
flash column chromatography on silica gel (elution: 40% to 100% EtOAc in hexanes and 
0% to 20% MeOH and EtOAc) to afford the product (74 mg, 0.25 mmol, 83% yield) as a 
mustard yellow solid: TLC (60% EtOAc in hexanes), R/i 0.45 (UV, KMn04); IR (film) 
3411, 3051, 2980, 2896, 1642, 1623, 1564, 1531, 1495, 1442, 1387, 1285, 1208, 1165, 
1029 cm 1; 'H NMR (400 MHz, CDCI3) 7.57 (d, J  = 7.42 Hz, 1H), 7.52-7.49 (m, 3H), 
7.37-7.34 (m, 2H), 7.29 (m, 1H), 7.05 (t, J =  7.82 Hz, 1H), 6.63 (d, ./=  7.82 Hz, 1H), 
4.34-4.30 (m, 2H), 3.89 (s, 2H), 2.93 (t, J=  7.03 Hz, 2H), 2.25-2.17 (m, 2H). 13C NMR 
(100 MHz, CDCI3) S 159.5,149.9, 148.0, 145.8, 140.3,136.4, 130.1, 128.8,128.0, 127.7,
126.2, 125.0, 123.7, 113.2, 77.3, 48.8, 34.9, 31.0, 21.8; Exact mass calcd for 
C2iHi7NONa [M+Na]+, 322.1202. Found 322.1200.
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(6*S',8aS)-dimethyl 6-benzyl-9-methoxy-5-oxo-2,3>5,6-tetrahydro-l//-6,8a-
(azenometheno)indolizme-7,8-dicarboxylate (40): To proline DKP, 14, (1.2 mmol) in 
toluene at -78 °C was added LiHMDS (1.0M in THF, 1.1 equiv.) dropwise over 5 
minutes by syringe. After stirring for 25 minutes at -78 °C, benzaldehyde (1.2 equiv.) 
was added to the solution. AC2O (1.3 equiv.) was added dropwise at -78 °C, and the 
solution was allowed to warm to room temperature while stirring. DBU (2 equiv.) was 
added and the mixture stirred at rt for 16 hours. The reaction was washed with NH4CI (20 
mL) and extracted with EtOAc (10 mL x 3). The organic layer was washed with brine (10 
mL), dried with Na2S04 , and then concentrated in vacuo. To the product (3.1 mmol) in 
DMF (20 mL) was added DMAD (1.2 equiv.). The reaction mixture was concentrated 
and purified by flash chromatography on silica gel (elution: 10%-50% EtOAc in 
hexanes) to afford a pale yellow solid (390 mg, 37% yield). TLC (60% EtOAc in 
hexanes), Rfi 0.60 (KMn04); IR (film) cm-13036, 2990, 2959, 2890, 1740, 1694, 1636, 
1496, 1434, 1388, 1206, 1144, 1097, 981, 1080, 894, 792, 698; H NMR (400 MHz, 
CDCI3) 7.57-7.55 (d, 2H, J=  7.0 Hz), 7.27-7.16 (m, 3H), 3.88 (s, 3H), 3.71 (s, 3H), 3.67 
(d, 1H, J  = 15.4 Hz), 3.45 (s, 3H), 3.18 (m, 1H), 2.80 (m, 1H), 2.49 (m, 1H), 2.04 (m, 
1H), 1.91 (m, 1H); 13C NMR (100 MHz, CDCI3) 8 174.2, 168.2, 164.9, 162.4, 152.3,
138.0, 136.6, 130.8, 127.5, 126.3, 74.3, 68.3, 56.4, 52.3, 52.2, 43.0, 35.0, 25.9, 
25.2; HRMS (ES+): Exact mass calcd for Czi^NzOeNa [M+Na]+ 421.1370 Found
421.1365.
MeO. CO?MeC 0 2Me
Ph
Ph
dimethyl 2-benzyl-5-(2-isocyanatoethyl)-6-methoxypyridine-3,4-dicarboxylate (41):
Cycloadduct 40 (20 mg, 0.05 mmol) in toluene (2 mL) was heated in the microwave at 
300 W for 1 hr 15 min. The reaction was concentrated to afford a clear colorless oil (15 
mg, 75% yield). TLC (60% EtOAc in hexane), R/: 0.70 (KMn04); IR (film) cm-1 2952, 
2277, 1735, 1653, 1576, 1440, 1297, 1262, 1194, 1089, 1075, 668; *H NMR (400MHz, 
CDCls) 7.31-7.26 (m, 3H), 7.22-7.16 (m, 2H), 4.29 (s, 2H), 3.96 (s, 3H). 3.89 (s, 3H), 
3.80 (s, 3H), 3.32-3.30 (t, J  = 6.4 Hz, 2H), 2.63-2.60 (t, J =  7.6 Hz, 2H), 1.88-1.83 
(quintet, J =  7.0 Hz, 2H); 13C NMR (100 MHz, CDC13) 167.8, 167, 3, 162,7, 157.5,
143.7, 139.4, 129.4, 128.6, 128.4, 126.5, 122.2, 119.1, 117.7, 54.5, 53.0, 52.7, 42.9, 42.0,
30.9, 24.6; HRMS (ES+): Exact mass calcd for C21H22N2O6 421.1370 Found 421.1366.
(65,8a1S)-dimethyl 6-benzyl-5,9-dioxo-2,3,5,6-tetrahydro-l/f-6,8a-
(epimmomethano)indolizine-7,8-dicarboxylate (42): Cycloadduct 40 (250 mg, 0.63
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mmol) in AcOH was added KI (3 equiv.) and stirred at 115 °C for 30 minutes. The 
reaction was diluted with water (50 mL) and Na2C03 (10%, 20 mL) and extracted with 
EtOAc (3 x 20 mL). The organic layer was washed with NaHC03 with thiosulfate (20 
mL), brine (20 mL), dried with Na2S04 , and concentrated in vacuo to afford a pale 
yellow powder (240 mg, 100%). TLC (60% EtOAc in hexane), R/: 0.30 
(KMn04); IR (film) cm-1 3220, 2955, 1715, 1670, 1497, 1405, 1283, 1146, 1039, 970; lH 
NMR (400MHz, CDC13) 7.39-7.27 (m, 5H), 5.86 (s, 1H), 3.92 (d, 1H, J=  15 Hz), 3.82 
(s, 3H), 3.80 (s, 3H), 3.52 (m, 1H), 3.34-3.27 (m, 2H), 2.83 (m, 1H), 2.30 (m, 1H), 2.09-
2.00 (m, 2H); 13C NMR (100 MHz, CDC13) 5169.6, 166.1, 163.7, 162.7, 147.7, 142.6,
133.4, 130.6, 129.2, 127.8, 70.9, 65.3, 52.8, 52.8, 43.8, 32.4, 25.7, 24.9; HRMS (ES+):
dimethyl 6-benzyl-5-oxo-l,2,3,5-tetrahydroindolizine-7,8-dicar boxy late (43): The
DMAD lactam cycloadduct, 42, (20 mg, 0.05 mmol) in AC2O (2 mL) was heated in a 
sealed tube to 140 °C for 17 hr and cooled to rt. The mixture was washed with NH4CI (20 
mL) and extracted with EtOAc (3x10 mL). The organic layer was washed with brine (10 
mL), dried with Na2S04, and then concentrated in vacuo. The product was purified by 
flash column chromatography (elution: 30-80% EtOAc in hexanes) to afford a white solid 
(15 mg, 84% yield). TLC (60% EtOAc in hexane), Rf: 0.20 (KMnO„); IR (film) cm"1
Exact mass calcd for C20H20N2O6 407.1214 Found 407.1209.
O
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2952, 1740, 1713, 1652, 1600, 1540, 1416, 1382, 1295, 1240, 1168, 1093, 1002, 737; ‘H
NMR (400MHz, CDC13) 7.35-7,34 (m, 2H), 7.26-7.24 (m, 2H) 7.15 (m, 1H), 4.16-4.13
(t, 2H, J=  7.6Hz), 3.88 (s, 2H), 3.82 (s, 6H), 3.50 (t, 2H, J=  7.8Hz), 2.19 (quintet, 2H, J
= 7.8Hz); 13C NMR (100 MHz, CDCI3) 167.9, 164.6, 161.1, 155.8, 142.2, 138.6, 129.0,
128.1, 126.6, 126.2, 102.7, 77.3, 52.5, 52.1, 49.7, 34.5, 33.6, 20.5; HRMS (ES+): Exact
mass calcd for C19H19NO5, 364.1155. Found 364.1151.
O O
NDMB
}
^  MeO- 
N TMS
OMe ^
(3^,7a*S)-9-(2,4-dimethoxybenzyl)-2-methoxy-4-(trimethylsilyl)-3,5,6,7-tetrahydro- 
3,7a-(epimmomethano)cyclopenta[£]pyridm-8-one (46): Prepared according to general 
procedure A using 15 (200 mg, 0.72 mmol). The product was purified by flash 
chromatography on silica gel (elution: 30% to 90% EtOAc in hexanes) to afford a yellow 
oil (260 mg, 87% yield): TLC (40% EtOAc in hexanes), R/i 0.15 (UV, CAM); IR (film) 
2959, 2839, 1679, 1615, 1576, 1506, 1459, 1405, 1333, 1250, 1140, 1035, 867, 843; (400 
MHz, CDCI3) 6.96 (dd, J  =8.42/1.6Hz, 1H), 6.40 (m, 2H), 4.66 (d, J  = 2.0 Hz, 1H), 4.41 
(dd, J=  14.7/1.4Hz, 1H), 4.19 (dd, J=  14.7/1.4 Hz, 1H) 3.784-3.782 (d, J  = 2.0 Hz, 3H), 
3.76-3.75 (d, J=  0.8 Hz, 3H), 3.624-3.622 (d, 0.8 Hz., 3H), 2.98 (m, 1H), 2.42 (m, 1H), 
2.31 (m, 1H), 2.08-2.00 (m, 2H), 1.83 (m, 1H) 0.00 (s, 9H); 13C NMR (100 MHz, CDC13) 
5 174.8, 170.5, 169.4, 160.4, 159.2, 130.8, 129.8, 116.7, 104.0, 98.1, 81.2, 79.0, 60.6,
55.1, 55.0, 54.7, 42.7, 29.5, 28.8, 26.3, -1.8. HRMS (ES+): Exact mass calcd for
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Ci4H2402Si [M+Na]+, 275.1438. Found 275.1439.
Ov^
NDMB 
H NyO ^-TM S
(3/?,7aiS)-9-(2,4-dimethoxybenzyl)-4-(trimethylsilyl)-3,5,6,7-tetrahydro-3,7a- 
(epiminomethano)cyclopenta[/>]pyridine-2,8(l//)-dione (47): Following general
procedure B, 46 (200 mg, 0.48 mmol) produced 47 without purification (170 mg, 88% 
yield) as a pale brown solid: TLC (60% EtOAc in hexanes), R/: 0.4 (UV, KMn04); IR 
(film) cm'13516, 3209, 2945, 2834, 1680, 1614, 1507, 1447, 1292, 1251, 1209, 1036; lH 
NMR (400 MHz, CDC13) 8.04 (br. s, 1H), 7.03 (dd, J  = 7.8/2.7Hz, 1H), 6.4-6.40 (m, 
2H), 4.45 (d, J  = 2.34, 2H), 4.08 (t, J  = 1.8Hz, 1H), 3.79-3.77 (t, J  = 3.7 Hz, 6H), 2.79 
(m, 1H), 2.44-2.40 (m, 2H), 2.09-2.03 (m, 2H), 1.91 (m, 1H), 1.77 (m, 1H), 0.00 (d, J  =
3.1 Hz, 9 H); 13C NMR (100 MHz, CDC13) 5 173.2, 169.4, 166.4, 160.8, 158.6, 134.1,
131.1, 116.4, 104.4, 98.5, 71.3, 65.5, 55.4, 55.3, 43.2, 29.0, 27.6, 26.6. HRMS (ES+): 
Exact mass calcd for C21H28N20 4Si [M+Na]+, 423.1711. Found 423.1714.
NDMB
O
V n d m b
° ? r s LHN—7 * ^ ^ — TMS
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2-(2,4-dimethoxybenzyI)-4-(trimethylsilyl)-2,5,6,7-tetrahydro-l//- 
cyclopenta[c]pyridin-l-one (48): Following general procedure C, using 47 (110 mg,
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0.28 mmol) the intermediate acylated product was produced (118 mg, 97% yield). This 
intermediate product was used (118 mg, 0.27 mmol) to produce the pyridone, 48, 
following general procedure D. The product was purified by flash column 
chromatography on silica gel (elution: 50% to 100% EtOAc in hexanes) to afford the 
product (85 mg, 0.24 mmol, 89% yield) as a brown oil: TLC (60% EtOAc in hexanes), 
Rf: 0.1 (UV, KMn04); IR (film) cm-13168, 2963, 2834, 2475, 2064, 1699, 1636, 1496, 
1456, 1374, 1319, 1253, 1041; ‘H NMR (400 MHz, CDC13) 7.43 (d, J  = 9.8 Hz, 1H), 
7.41 (s, 1H), 6.43 (d, J  = 2.0, 2H), 5.05 (s, 2H), 3.83 (s, 3H), 3.76 (s, 3H), 2.82-2.76 
(quartet, J  = 7.8 Hz, 4H), 2.03-1.99 (quintet, 7.6 Hz, 2H) ; 13C NMR (100 MHz, CDCI3) 
8 161.0, 160.6, 158.4, 157.9, 141.8, 132.5, 131.6, 117.4, 111.2, 105.0, 98.2, 55.3, 55.1,
46.4, 34.9, 29.5, 23.4, -0.9. HRMS (ES+): Exact mass calcd for C2oH27N0 3 Si [M+Na]+, 
380.1652. Found 380.1655.
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Chapter 3
Synthesis of Louisianin B
Isolation of Louisianins
In 1995, Omura and co-workers isolated Louisianins A through D from a cultured 
broth of Streptomyces sp. WK-4028 from a soil sample collected in Louisiana.1 
Louisianins A (1) and B (2) are pyridones, while Louisianins C (3) and D (4) are 
pyridines (Figure 3.1). Members of this small family of molecules share a common 
feature that the pyridine or pyridone core is fused with a five-membered ring at the C-3 
and C-4 positions. Louisianin B has a hydroxyl group instead of a carbonyl on the 
cyclopentane ring, giving it a stereocenter; however, Omura did not determine the 
stereochemistry of the natural product.
NH NH
HO
Louisianin A (1) Louisianin B (2) Louisianin C (3) Louisianin D (4)
Figure 3.1 Louisianin family structures
Louisianin A has been shown to inhibit the growth of SCI 15 cancer cells, a class
of androgen-dependent mouse mammary tumor cells. Louisianins C and D are isolated in
very small amounts. To acquire sufficient material for the determination of biological
activity, Omura demonstrated that the conversion of louisianin A to both
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louisianin C and D was possible in 51% and 43% yields, respectively. After obtaining 
ample amounts of the pyridine natural products, it was determined that louisianin C and 
D are suppressors of vascular endothelial cells.
Previous Syntheses of Louisianin Family
Kelly, in 2003, completed the first synthesis of a member of the louisianin family, 
louisianin C (Scheme 3.1). Beginning with a symmetrical 3,5-dibromopyridine, Kelly 
treated the pyridine with LDA and trapped the lithiated intermediate with TMS Cl to form 
5. A double Stille coupling produced allylated pyridine 6 . Hydroboration and oxidation of 
one allyl residue preceded formation of alcohol 7 followed by oxidation using 
iodoxybenzoic acid, IBX. TBAT was then used to fluorinate the TMS group, forming 8 
which possesses more nucleophilic character at position 4 of the pyridine ring. This set 
up for subsequent desilylation and cyclization through nucleophilic addition into the 
aldehyde. An oxidation using CrC>3 provided the final product, louisianin C (3), in six 
steps with 11% overall yield. Kelly demonstrated how functionalization of a 
commercially available symmetric pyridine could construct the desired natural product.
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75%
Louisianin C (3)
Scheme 3.1 Kelly’s synthesis of louisianin C
In 2006, Chang reported the first synthesis of louisianin A from a starting 
asymmetrical 2-chloro-4-cyanopyridine (Scheme 3.2).4 The C-3 position was 
deprotonated using LDA and subsequently iodinated. A Heck reaction was then utilized 
to couple the pyridine to methyl acrylate. This product 9 was then hydrogenated to afford 
the saturated chain, which would later be transformed into the fused cyclopentane ring 
system. A bromine was next attached at C-5, setting up for a Stille coupling to add the 
pendant allyl group onto the pyridine ring to form 10. Finally, cyclization occurred 
through a Dieckmann condensation, in which nucleophilic attack on the nitrile closes the 
cyclopentanone ring and is followed by decarboxylation to form the final pyridone,
louisianin A (1), in seven overall steps with 24% yield.
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Lousianin A (1)
Scheme 3.2 Chang’s synthesis of louisianin A
Previous syntheses of this family of molecules involved using a commercially 
available pyridine as the starting material. In 2006, Chang was able to synthesize 
louisianin D (4) in 10 steps with 20% yield overall. This was achieved by accessing a 
glutarimide through a [3+3] annulation of an a-sulfonyl acetamide with an a,(3- 
unsaturated ester.5 Subsequent aromatization and allylation were required to achieve the 
desired natural product.
The previous syntheses were able to form louisianin A, C, and D. Louisianin B 
had not been synthesized until Taylor, in 2009, was able to access all four members of the 
louisianin family through an inverse electron demand Diels-Alder.6 A 1,2,4-triazine was 
used as the azadiene for the Diels-Alder. First, Taylor had to construct the triazine core
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(Scheme 3.3). This required the condensation between 11 and 12 to form an amidrazone 
hydrazone, which underwent subsequent oxidative cyclocondensation to produce the 
needed triazine, 13. This set up for the cycloaddition with an enamine, which is followed 
by cycloreversion in one pot with loss of diatomic nitrogen. This successfully constructed 
the pyridine core that was the common intermediate 14 on route to all four louisianin 
family members.
Scheme 3.3 Taylor’s route to common intermediate
For the route to louisianin C and D, decarbonylation occurred after washing with 
dilute HC1, and oxidation of the cyclopentane ring was accomplished using LiHMDS and 
molecular oxygen to produce benzylic alcohol 15 (Scheme 3.4). The sulfide was then 
oxidized to the sulfoxide using m-CPBA, followed by heating to eliminate the 
benzenesulfonic acid. The secondary alcohol was then oxidized to reveal louisianin C (3) 
in 11 steps with 7.2% overall yield. Louisianin C was then converted into louisianin D (4) 
through an isomerization of the allyl group using 7-methyl-1,5,7-triazabicyclo[4.4.0]dec-
5-ene (MTBD) in toluene and heating to 80 °C. Louisianin D was synthesized in 12 steps 
with a 5.6% yield overall.
1) EtOH, 
rt, 2 h
tol, microwave 
1 2 0 °C, 1 h 
89%
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SPh
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C 0 2Et dil. aq. HCI,
1 microwave,
185 °C, 1 h
LHMDS, P(OEt)3, 
0 2> THF, -5 °C 8 h
83% 80%
OH
SPh SPhSPh
14 15
i) m-CPBA, CH2CI2, 
-78 °C 1 h
ii) C aC 03, xylene, 
160 °C, 18 h
76%
MTBD, tol, 
80 °C 6 h
p c c /ai2o 3,
CH2CI2, rt, 3 h N
78% 80%
OH
Louisianin C (3)Louisianin D (4)
Scheme 3.4 Taylor’s synthesis toward louisianin C and D
After producing the two pyridine natural products, Taylor aimed to synthesize the
pyridones, louisianin A (1) and B (2). Using common intermediate 14, Taylor converted
the ethyl ester into an acid using TMSOK (Scheme 3.5). The acid underwent radical
decarboxylative halogenation through a Barton ester intermediate. An oxidation similar
to that used toward louisianin C and D installed the benzylic alcohol functionality. A
Parikh-Doering oxidation was then used to convert this benzylic alcohol into a ketone.
Next, treatment with acetic acid and water hydrolyzed the chloropyridine to form the
desired pyridone core 16. A similar approach for the allylation was subsequently
employed to form louisianin A (1) in 11 steps with an overall yield of 3.8%. To access
louisianin B required a reduction to form the benzylic alcohol. This was done in two
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ways, either to form the racemic mixture or an enantiopure product. The racemic method 
required a sodium borohydride reduction; Taylor was able to synthesize racemic 
louisianin B (2) in 12 steps with an overall yield of 3.1%. The enantioselective synthesis 
of (-)-louisianin B was completed through a Noyori reduction using a ruthenium catalyst. 
The total synthesis of enantiopure (-)-louisianin B was completed in 12 steps in a 3.5% 
overall yield.
TMSOK
DMAP, DCC, 
CCI4 A, 24 h 
56%
LHMDS, 
P(OEt)3, 
0 2, THF, 
-15 °C, 3 h 
86%SPh SPh SPh14
AcOH/H20  (9:1), 
135 °C, 72 h NHN
92% 75%
i)m-CPBA, 
CH2CI2, -15 °C
ii) Et3N, rt, 0.5 h
iii) CaC03  
xylene, 160 °C
71% 
over 2 steps
OH
SPh SPhSPh
1) 5 mol%-(S,S)-Noyori 
Et3N/HC03H (5:2), 
DMF, 40 °C, 24 h; 
92% e.r. >99:<1 HN
or
2) NaBH4, MeOH, 
rt 1h 
82% (+/-)
OH
Louisianin A (1) Louisianin B (2)
Scheme 3.5 Taylor’s synthesis toward louisianin A and B
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Route Towards Louisianin B
Having optimized cycloreversion conditions on model substrates, we anticipated 
an application toward the synthesis of louisianin B. We envisioned a late stage oxidation 
to install the hydroxyl functionality on the fused cyclopentane ring system, followed by a 
deprotection of the pyridone nitrogen to reveal the final natural product (Scheme 3.6). A 
similar sequence as described in Chapter 2 would be used to convert the cycloadduct 17 
into the desired pyridone. This cycloadduct would be constructed from the DMB DKP 18 
and aliphatic aldehyde 19.
NH Deprotection NDMB
HO
NDMBCycloreversion
Domino
Sequence
O
NDMB
N 
OMe
19 18
Scheme 3.6 Retrosynthesis of louisianin B route
Aldehyde 19 was simple in construction, first requiring an allylation of pent-4-yn-
l-ol using allyl bromide, potassium carbonate, tetrabutylammonium chloride, and copper
(I) chloride as a catalyst. Once the alkyne was allylated, it was oxidized using Parikh-
Doering conditions to reveal the final aldehyde 19 with yield of 67% over two
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Allylation and 
Oxidation
steps. With the aliphatic aldehyde in hand, we attempted the one pot sequence with the 
DMB protected DKP 18 (Scheme 3.7). Enolization of 18 with LiHMDS was followed by 
addition of the aldehyde. Acetic anhydride was added to facilitate acetyl elimination upon 
addition of DBU. Subsequent isomerization converted the elimination product into the 
desired endo azadiene, setting up for an intramolecular Diels-Alder cycloaddition to 
produce cycloadduct 17.
To access the desired louisianin pyridone, this cycloadduct was then submitted to 
the conditions that were optimized in the methodological section. Potassium iodide and 
acetic acid were used to deprotect the lactim ether bridge to form 20 , which could then be 
functionalized with the electron-withdrawing acetate group. Microwave irradiation was 
then able to afford the desired protected pyridone 21. After this, the only remaining step 
besides deprotection was the oxidation of the benzylic position of the cyclopentane to 
yield louisianin B.
i) LiHMDS, -78  °C
ii) O
O
r 1' NDMB
OMe
18
iii) Ac20, -78  °C to rt
iv) DBU rt to 90 °C
82%
NDMB NDMBAcOH, 
100 °C
MeO.
-► HN
90%
2017
[Ox]
Deprotection
Louisianin B (2)
O
NDMB
21
Microwave
Ac20  
100 °C
O^NDMB
72% 
over 2 steps
Scheme 3.7 Synthetic scheme towards louisianin B with aliphatic aldehyde
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Since the desired oxidation position was benzylic with the most nucleophilic 
character, we anticipated that the pyridone would most likely enolize at that position. 
LiHMDS and LDA proved not to' form the enolate, resulting in starting material. 
Knowing that enolization was the problematic step, we looked to use potassium t- 
butoxide as the base. Three equivalences of potassium /-butoxide caused oxidation at the 
desired benzylic position; however, we also observed isomerization of the allyl group 
resulting in 22 in 64% yield (Figure 3.2).
O O O
NDMB
HO
NH
HO
NDMB
louisianin B 22 23
Figure 3.2 Louisianin B and products from KOtBu oxidations
For this reason, we wanted to determine whether the isomerization or oxidation was 
occurring first; to accomplish this, we performed the reaction at 0 °C with only one 
equivalence of base. From this, we could determine that the isomerization was occurring 
first, forming 23. Since the allyl group was inadvertently affected by the late stage 
oxidation, we concluded that oxidation could not be performed after installation of the 
allyl group without isomerization.
In 2006, Chang used potassium /-butoxide to isomerize an allyl group that had 
been installed on a pyridine ring in their synthesis of louisianin D, although their work
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required the system to be heated to reflux in THF.5 Our experiment showed that even 
though the isomerization required heat for Chang, we were able to isomerize and oxidize 
our pyridone core at 0 °C.
Revised Route Towards Louisianin B
Because alkene isomerization during oxidation could not be prevented, we aimed 
to synthesize an oxygenated aldehyde. It was unclear whether a substrate with a P-alkoxy 
group would be compatible with the reaction conditions that had been optimized to form
2-pyridones. To form the desired azadiene 24 for the reaction sequence, DBU must 
deprotonate Ha; however, deprotonation of Hb was possible, which could eliminate the (3- 
alkoxy group to form elimination product 25 (Figure 3.3).
OR O
Deprotonate
Ha R T  Tf NDMB
OR O
R I NDMB
Hb
OMe
DBU
^  Hb N.
OMe 
24
Deprotonate O
  — R ^ x ^ T ^ N D M B
N" '  'H a 
OMe
25
Figure 3.3 Possible sites of deprotonation to form azadiene or elimination product
Even though it could not be predicted which position would deprotonate first, we 
proposed a scheme in which the aldehyde would be constructed with a (3 functionality and
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carried through the domino sequence. This would set up for use of the optimized 
cycloreversion conditions from Chapter Two and finally a deprotection of the pyridone 
and benzylic alcohol to reveal louisianin B (Scheme 3.8).
NH Deprotection NDMB Cycloreversion
C>
V n d m b
* M eoM \ Z ^ =■trOR
EtO
Alkynylation,
OEt q  Allylation and O OR
I || Deprotection
A ^ O E t  < H
Domino
Sequence
NDMB
N.
OMe
Scheme 3.8 Retrosynthesis of revised route using oxidized aldehyde
We decided to form the alkyne functionality through addition into the carbonyl. 
This step would install the alkyne as well as form the alcohol that is present in louisianin 
B. Beginning with diethoxy propanoate, 26, we reduced the ethyl ester to aldehyde 27 
(Scheme 3.9). This reduction set up for the Grignard addition of ethynylmagnesium 
bromide into the aldehyde to form secondary alcohol 28. Because of the non- 
stereospecific manner of the Grignard reaction, two enantiomers were produced and 
carried through the route. Initial attempts to attach an allyl group to the alkyne used the 
same conditions as the initial route with allyl bromide, potassium carbonate, 
tetrabutylammonium chloride, and the copper (I) chloride catalyst. It was noted that in
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one instance, the alcohol was allylated. For this reason, we first protected the alcohol 
with TBS Cl to prevent undesired allylation. Once the alcohol 29 was protected, we could 
use a stronger base, specifically w-BuLi, to deprotonate the alkyne, which could then act 
as the nucleophile and undergo an Sn2 displacement with allyl bromide to form the 
allylated product 30. The last step required deprotection of the acetal to reveal the final 
oxygenated aldehyde 31.
= — MgBr
THF, -78 °C 
to rt
OEt OHOEt O 
27
^  EtO
71%
28 Br
CuCI, K2CO. 
TBACI, 
DMF, rt
TBSCI, 
imidazole, 
DMF, rt 
97% /
OEt OTBS i)n-Bul_i, THF, -78 °C, OEt OTBS OEt OH
EtO ii)
CuBr*SMe2, 50 °C 
96%
EtO EtO
30
+
OTBS EtO
31
Scheme 3.9 Synthesis of oxidized aldehyde
The aldehyde is sensitive and must be used directly. Both stable aldehyde hydrate 
32 and the product 33 arising from elimination of the (3-siloxy residue are observed 
(Figure 3.4). Overall, the oxidized aldehyde could be synthesized in 5 steps with 30% 
yield.
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32 33
Figure 3.4 Structure of hydrate and elimination products
With the oxygenated aldehyde, we were able to attempt a one-pot domino 
sequence using the DMB DKP (Scheme 3.10). However, initial efforts with the one-pot 
reaction resulted in a majority of DKP starting material. We proposed that the 
problematic step in the reaction sequence was the aldol addition and have been currently 
adjusting conditions to optimize the sequence. Two diastereomeric cycloadducts 34a and 
34b were synthesized from the domino sequence, differing at the stereocenter containing 
the TBS protected alcohol with a diastereomeric ratio of 3:2. This demonstrated that the 
P-siloxy group did not have a significant impact on the diastereoselectivity of the 
cycloaddition.
The lactim ether deprotection in acetic acid risked loss of the TBS group; 
however, we did not observe this with our product. Once lactam 35 was formed, we 
acetylated it and submitted the product to microwave irradiation without purification. Use 
of the microwave for one hour and fifteen minutes resulted in the desired protected 
pyridone 36.
The only remaining step required to access louisianin B was the removal of both
the DMB and TBS groups. We anticipated that we could cleave both protecting groups
simultaneously with the TFA conditions that we had previously utilized to cleave
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the DMB group. After submission to the microwave for 10 minutes in 2:1 CFbC^TFA, 
using temperature mode that would hold at 120 °C, we observed that complete conversion 
was not achieved. We resubmitted the reaction mixture and held it at 120 °C for 30 
minutes. It was observed that both the DMB group as well as the TBS group had been 
cleaved. Comparing our ]H NMR spectrum to Taylor’s supported that we had 
successfully constructed louisianin B. Overall, there were 10 steps in our synthesis with 
an overall yield of 1.5% to access the desired pyridone.
O
NDMB
N.
OMe
18
i) LiHMDS, -7 8  °C 
jj) O OTBS
MeO
iii) Ac20 ,  - 7 8  °C to rt
iv) DBU rt to 90 °C
29%
NDMB
Q
Microwave 
300 Watts AcO
'VNDMB
59%
OTBS
O
NDMB
TBSO
36
2:1 CH2CI2:TFA, 
microwave, temp mode, 
120 °C, 30 minutes
32%
Kl,
  AcOH,
—  1 0 0 °C
91%
34
OTBS
O
NH
HO
Louisianin B (2)
Ac20,
100 °C O;
hn;
NDMB
35 OTBS
Scheme 3.10 Revised synthesis toward louisianin B with oxidized aldehyde
By forming an oxygenated aldehyde, we were able to construct the
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louisianin pyridone core efficiently, which revealed the final natural product after 
removal of two protecting groups. Previously, only non-oxygenated aldehydes had been 
utilized in our one-pot domino sequence, and it is interesting that the protected alcohol 
was able to persist through the cycloreversion conditions. This example suggests that a 
wider group of aldehydes could potentially be used to access pyridones with these types 
of oxygenated substituents.
Conclusion
Overall, we were able to demonstrate the applicability of our methodological 
work by applying it to the synthesis of louisianin B. We initially had attempted to use an 
aliphatic aldehyde to achieve this goal, but a late stage oxidation proved to be 
incompatible with the allyl substituent on the pyridone core. Eventually, we were able to 
synthesize an aldehyde with a protected alcohol in the (3 position and use it in the domino 
sequence to construct the desired [2.2.2]-diazabicyclic core. Furthermore, the protected 
alcohol was able to withstand the conditions to form the 2-pyridone, showing a 
potentially useful set of new aldehydes that could be explored with these conditions. 
While conditions for this route have not yet been fully optimized, we have been able to 
show that the final natural product can be formed through this sequence of conditions. 
Overall, we have demonstrated the synthesis of louisianin B in 10 steps with a 1.5% 
yield.
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E xp erim en ta l S ec tio n
o
oct-7-en-4-ynal (19). To oct-7-en-4-yn-l-ol (400 mg, 3.2 mmol) dissolved in 
dichlormethane (10 mL) was added i-P^NEt (1.7 mL, 9.7 mmol) at 0 °C. A stock 
solution of S03 pyr (790 mg, 4.8), DMSO (7.5 mL) in dichloromethane (4.5 mL) was 
prepared at 0 °C. Small increments of the stock solution were added to the reaction flask 
until the reaction appeared to be complete as tracked by TLC. The reaction appeared to 
be complete after about 1 hr. After cooling, the reaction was diluted with HC1 (10 mL) 
and the organic layer was extracted with Et20 (3x10 mL). The combined organic layers 
were diluted with NaHC03 (10 mL), washed with brine (10 mL), dried with NaS04 , 
filtered and concentrated in vacuo. The product was purified by flash chromatography on 
silica gel (elution: 5% to 25% Et20 in pentane) to afford product oct-7-en-4-ynal (265 
mg, 67% yield) as colorless liquid; TLC (40% EtO Ac in hexane) Rf= 0.60 (KMn04); IR 
(film) cm-1 3086, 3014, 2982, 2904, 2830, 2731, 1718, 1642, 1412, 1358, 1286, 1193, 
1058, 993, 918, 850; !H NMR (400MHz, CDC13) 9.80 (s, 1H, CHO), 5.79 (m, 1H, C7H), 
5.28 (ddd, J=  16.8/3.1/1.6 Hz, 1H), 5.10 (dt, J  = 9.8/1.6 Hz, 1H), 2.93-2.91 (m, 2H), 
2.68-2.66 (m, 2H), 2.54-2.50 (m, 2H) ; 13C NMR (100 MHz, CDC13) 5 200.6, 132.7,
115.6, 80.3, 77.6, 42.7, 22.8, 11.9 ; Exact mass calcd for C8Hi0ONa [M+Na]+, 267.1356, 
Found 267.1354.
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NDMB
NDMB
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(3£,7aS)-4-allyl-9-(2,4-dimethoxybenzyl)-2-methoxy-3,5,6,7-tetrahydro-3,7a- 
(epiminomethano)cyclopenta[£>]pyridin-8-one (17): To diketopiperazine 18 (195 mg, 
0.68 mmol) in toluene (7 mL) at -78 °C was added LiHMDS (1.0M in THF, 1.1 equiv.) 
dropwise over 5 minutes by syringe. After stirring for 25 minutes at -78 °C, aldehyde 18 
(125 mg, 1.2 equiv.) was added to the solution. AC2O (0.093 ml, 1.3 equiv.) was added 
dropwise at -78 °C, and the solution was allowed to warm to room temperature while 
stirring. DBU (0.203 ml, 2 equiv.) was added and the mixture stirred at rt for 16 hours. 
The reaction was washed with NH4CI (20 mL) and extracted with EtOAc (10 mL x 3). 
The organic layer was washed with brine (10 mL), dried with Na2SC>4, and then 
concentrated in vacuo. The reaction mixture was concentrated and purified by flash 
chromatography on silica gel (elution: 10% - 50% EtOAc in hexanes) to afford a pale 
yellow oil (220 mg, 82% yield). TLC (40% EtOAc in hexanes), R/i 0.25
30.0, 26.2, 26.1; HRMS (ES+): Exact mass calcd for C22H26N204Na [M+Na]+ 405.1784
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(CAM); IR (film) cm-1; H NMR (400 MHz, CDC13); 6.94 (d, 1H, J =  7.8 Hz), 6.37 (s, 
1H), 6.35 (d, 1H, J=  7.0 Hz), 5.52 (m, 1H), 4.94 (s, 2H, J=  10.2), 4.75 (d, 1H J=  1.6),
4.37 (s, 1H), 4.30 (m, 2H), 3.73(s, 3H), 3.72 (s, 3H), 3.60 (s, 3H), 2.88 (m, 1H), 2.68 (dd,
1H, J  — 15.6/6.3), 2.52 (dd, 1H, J  = 15.6/6.6 Hz), 2.25 (m, 1H). 2.14 (m, 1H), 2.06-1.96 
(m, 2H), 1.70 (m, 1H); 13CNMR(100 MHz, CDC13) 5 175.3, 171.8, 160.6, 158.4, 151.8,
133.9, 131.0, 130.6, 116.9, 116.6, 104.0, 98.1, 79.7, 61.1, 55.2, 55.0, 54.9, 42.8, 34.2,
Found 405.1784.
NDMB NDMB
^  HN
(3*S,7aS)-4-allyl-9-(2,4-dimethoxybenzyl)-3,5,6,7-tetrahydro-3,7a- 
(epiminomethano)cyclopenta|7>] pyridine-2,8(1//)-dione (20): To product 17 (150 mg, 
0.39 mmol) in AcOH was added KI (3 equiv.) and stirred at 100 °C for 2.45 hr. The 
reaction was diluted with water (20 mL) and Na2CC>3 (10%, 10 mL) and extracted with 
EtOAc ( 3 x 1 0  mL). The organic layer was washed with NaHC03 with thiosulfate (10 
mL), brine (10 mL), dried with Na2S04 , and concentrated in vacuo to afford a tan powder 
(130 mg, 90% yield). TLC (60% EtOAc in hexane), Rf. 0.35 (KMn04); IR(film) cm-1 
2960,2838, 1696, 1663,1456, 1418, 1294, 1210, 1158, 1039, 922, 826; *H NMR 
(400MHz, CDC13) 7.75 (br. s, 1H), 7.05 (d, J=  8.6 Hz, 1H), 6.43-6.38 (m, 2H), 5.53 (m, 
1H), 4.99 (d, .7=10.2 Hz, 1H), 4.93 (dd, J=  16.8/1.6Hz, 1H), 4.54 (d, J=  14.5 Hz, 1H),
4.38 (d, 14.5 Hz, 1H), 4.20 (d, J  = 1.6 Hz, 1H), 3.79 (s, 3H), 3.76 (s, 3H), 2.74 (m, 2H), 
2.59 (dd, J  = 15.2/5.9 Hz, 1H), 2.33-2.30 (m, 2H), 2.06-1.88 (m, 1H), 1.86-1.78 (m, 
1H), 1.77-1.67 (m, 1H); 13C NMR (100 MHz, CDC13) 173.9, 170.3, 160.8, 158.6, 149.4,
133.7, 133.3, 131.3, 117.3, 116.6, 104.1, 98.3, 70.2, 65.8, 55.3, 55.1, 43.3, 34.7, 27.7,
26.4, 26.3; HRMS (ES+): Exact mass calcd for C21H24N2O4 [M+Na]+, 391.1628. 
Found 391.1624.
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4-allyl-2-(2,4-dimethoxybenzyl)-2,5,6,7-tetrahydro-l//-cyclopenta[c]pyridiii-l-one 
(21): The lactam cycloadduct 20 (32 mg, 0.087) in AC2O (0.2 mL) and pyridine (0.2 mL) 
was heated in a sealed tube to 100 °C for 19.5 hr and cooled to rt. The mixture was 
concentrated in vacuo. The intermediate product was dissolved in toluene (2 mL) and 
heated in a microwave system on power mode (300 W maximum) for 1.5 hr. The reaction 
was concentrated in vacuo to afford a tan solid (25.8 mg, 91% yield). TLC (60% EtOAc 
in hexane), Rfi 0.25 (CAM); IR (film) cm-1 2956, 2849, 1696, 1646, 1561, 1457, 1290, 
1267, 1210, 1158, 1032, 920, 836; *H NMR (400MHz, CDC13) 7.35 (d, .7=9.0 Hz, 1H), 
7.12 (s, 1H), 6.45-6.42 (m, 2H), 5.83 (m, 1H), 5.15 (m, 3H), 3.82 (s, 3H), 3.78 (s, 3H), 
3.08-3.06 (d, J  = 6.3 Hz, 2H), 2.87-2.82 (t, J  =7.42 Hz, 2H), 2.77-2.74 (t, J=  7.4 Hz, 
2H), 1.87 (m, 3H); 13CNMR(100 MHz, CDC13) 160.6, 158.4, 154.6, 135.8, 134.6, 131.9,
117.5, 116.3, 114.8, 104.1, 98.3, 55.3, 55.2, 46.6, 34.2, 32.4, 30.3, 23.2; HRMS (ES+): 
Exact mass calcd for C20H23NO3 [M+Na]+, 348.1570 Found 348.1566.
5,5-diethoxypent-l-yn-3-ol (28): To 3,3-diethoxypropanal (1.1 g, 8.22 mmol) in THF
(70 mL) at -78 °C was added ethynyl magnesium bromide (22.5 mL, 0.5 M, 12.4 mmol)
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dropwise. The reaction vessel was slowly warmed to room temperature and then stirred 
overnight. The reaction was washed with NH4CI (50 mL) and extracted with EtOAc (3 x 
25 mL). The organic layer was washed with brine (30 mL), dried with Na2S04 , and then 
concentrated in vacuo. The reaction mixture was purified by flash chromatography on 
silica gel (elution: 5%-50% EtOAc in hexanes) to afford a yellow oil (925 mg, 71% 
yield). TLC (40% EtOAc in hexanes), Rf: 0.40 (KMn04); IR (film) cm-1 3419, 3294, 
2973, 2892, 2118, 1445, 1375, 1349, 1215, 1130, 1057, 848, 806; H NMR (400 MHz, 
CDCI3) 4.77 (t, J=  5.67 Hz, 1H), 4.46 (m, 1H), 3.68-3.53 (m, 2H), 3.52-3.41 (m, 2H), 
2.41 (d, J=  1.95 Hz, 1H), 1.96 (t, J=  5.67 Hz, 2H), 1.18-1.05 (m, 6H); 13C NMR (100 
MHz, CDCI3) 6 101.0, 84.1, 72.7, 62.3, 61.8, 58.9, 40.2, 15.2, 15.2; HRMS (ES+): Exact 
mass calcd for [M+Na]+, 195.0992. Found 195.0993.
OEt OH OEt OTBS
terr-butyl((5,5-diethoxypent-l-yn-3-yl)oxy)dimethylsilane (29): To 28 (200 mg, 1.16 
mmol) in DMF (0.6 mL) was added imidazole (166 mg, 2.44 mmol) stirred at rt for 30 
min. Tert-butyl chlorodimethylsilane (192.9 mg, 1.28 mmol) was added at rt and the 
reaction was allowed to stir overnight. The reaction was diluted with water (mL), 
extracted with EtOAc (3 x mL). The organic layer was washed with brine (mL), dried 
with Na2S04 , and concentrated in vacuo to afford a yellow oil (322 mg, 97% yield). TLC 
(40% EtOAc in hexane), Rf. 0.70 (KMn04); IR (film) cm-1 3312, 2978, 2934, 2858, 
2110. 1718, 1636, 1617,1374, 1275, 1123, 1093, 1062, 935, 840;‘H NMR (400MHz,
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CDC13) 4.58 (dd, J=  4.86/1.95 Hz, 1H), 4.21 (m, 1H), 3.64-3.33 (m, 2H), 2.32 (d, J  = 
2.35 Hz, 1H), 1.98-1.85 (m, 2H), 1.14-1.10 (td, J=  7.03/2.34 Hz, 6H), 0.82 (s, 9H), 
0.06-0.03 (d, J=  14.8 Hz, 6H); 13C NMR (100 MHz, CDC13) 99.9, 85.1, 72.4, 61.7, 61.2,
59.5, 42.6, 25.7, 18.1, 15.3, 15.25, -4.6, -5.3; HRMS (ES+): Exact mass calcd for 
[M+Na]+, 309.1856. Found 309.1858.
OEt OTBS OEt OTBS
EtO
ter/-butyl((l,l-diethoxyoct-7-en-4-yn-3-yl)oxy)diinethylsilaiie (30): To 29 (250 mg, 
0.87 mmol) in THF (0.6 mL) at -78 °C was added n-BuLi (2.84M, mmol) dropwise. The 
reaction was stirred for 30 min at -78 °C. To the solution was added allyl bromide (92 pi, 
1.07 mmol) and copper (I) bromide dimethyl sulfide (9.2 mg, 0.045 mmol) and the 
reaction was heated to 50 °C overnight. The mixture was washed with NH4CI (10 mL), 
extracted with EtOAc ( 3 x 1 0  mL). The organic layer was washed with brine (10 mL), 
dried with Na2S04  and concentrated in vacuo to afford a yellow oil (268 mg, 94% yield). 
TLC (40% EtOAc in hexane), Rfi 0.80 (KMn04); IR (film) cm-1 2978, 2935, 2860, 1643, 
1373, 1351, 1253, 1123, 19087, 1074, 985, 915, 834, 778; lU NMR (400MHz, CDC13)
5.77 (m, 1H), 5.28 (d, J=  17.2 Hz, 1H), 5.08 (dd, J=  9.96 Hz, 1H), 4.65 (t, J=  5.28 Hz, 
1H), 4.48 (m, 1H), 3.56 (m, 4H), 2.96-2.94 (m, 2H), 1.97 (m, 2H), 0.884-0.881 (d, J  =
1.77 Hz, 9H), 0.79-0.09 (d, J=  11.9/0.78 Hz, 6H); 13C NMR (100 MHz, CDC13) 132.3,
115.9, 100.0, 83.8, 81.0, 61.5, 60.928, 59.9, 42.9, 25.7, 25.6, 22.9, 18.0, 15.3, 15.2, -4.5,
83
-5.2; HRMS (ES+): Exact mass calcd for C20H23NO3 [M+Na]+, 349.2169.
Found 349.2169.
OEt OTBS O OTBS
3-((te/T-butyldimethylsilyl)oxy)oct-7-en-4-ynal (31): To 30 (225 mg, 0.69 mmol) 
dimethylsilane dissolved in CHCl3(6 mL) was chilled to 0 °C. A 1:1 mixture of TFA in 
FLO (6 mL) was added dropwise. The reaction was allowed to stir at 0 °C for 2.5 h and 
warmed to room temp and allowed to stir for 3 h. The reaction was quenched with 
NaHCOs (10 mL), extracted with CHCI3 (3x10 mL). The organic layer was washed with 
brine (10 mL), dried with Na2S04  and concentrate in vacuo to afford a pale yellow oil 
(102 mg, 59% yield). TLC (40% EtOAc in hexane), R/: 0.85 (KMnOzO; IR(film) cm-1 
2959, 2934, 2887, 2856, 2740, 2711, 2234, 1732, 1696, 1636, 1561, 1458, 1339, 1282, 
1143, 988, 914, 835, 781; *H NMR (400MHz, CDC13) 9.71 (s, 1H), 5.66 (m, 1H), 5.16 
(dq, 1H, J =  17.2/1.7 Hz), 5.00 (dq, 1H, J =  10.2/1.6 Hz), 4.76 (m, 1H) 2.87-2.84 (m, 
2H) 2.66-2.51 (qdd, J=  17.3/6.2/2.8 Hz, 2H), 0.88 (s, 9H), 0.15 (s, 3H), 0.12 (s, 3H); 13C 
NMR (100 MHz, CDCI3) 200.8, 132.0, 116.2, 82.8, 82.4, 58.5, 51.6, 25.6, 22.0, 18.0, -
4.5, -5.2; HRMS (ES+): Exact mass calcd for CwHwOiSi [M+Na]+, 275.1438. 
Found 275.1440.
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(35',7aS)-4-allyl-5-((fc^-butyldimethylsilyl)oxy)-9-(2,4-dimethoxybenzyl)-2-methoxy- 
3,5,6,7-tetrahydro-3,7a-(epimmomethano)cyclopenta[£]pyridin-8-one (34a and 34b):
Prepared according to general procedure A using DKP 17 (50 mg, 0.18 mmol) and 
aldehyde 31. The product was purified by flash chromatography on silica gel (elution:) to 
afford two diastereomers as clear oils (34a: 15 mg, 0.029 mmol, 16% yield) (34b: 12 mg, 
0.023 mmol, 13% yield): 33a: TLC (40% EtOAc in hexane), R/i 0.55 (UV, CAM); ]H 
NMR (400 MHz, CDC13) 7.00 (d, J= 7 A Hz, 1H), 6.44-6.40 (m, 2H), 5.56 (m, 1H), 5.04 
(d, J=  9.8 Hz, 1H), 4.93 (dd, J  = 17.2/1.6 Hz, 1H), 4.73 (t, J  = 5.67 Hz, 1H), 4.45 (s, 
1H), 4.36 (s, 1H), 3.81 (s, 3H). 3.79 (s, 3H), 3.68 (s, 3H), 2.94 (dd, J  = 15.6/5.9, 1H), 
2.80-2.66 (m, 2H), 2.37 (m, 1H), 2.10-1.93 (m, 2H), 1.67 (s, 9H), 0.07 (s, 3H), 0.03 (s, 
3H); 13C NMR (100 MHz, CDC13) 5 176.0, 172.2, 160.8, 158.5, 152.0, 134.7, 134.1, 
131.3, 117.3, 117.1, 104.8, 104.1, 98.4, 78.0, 70.6, 61.8, 55.4, 55.3, 55.2, 43.0, 36.3, 33.0,
26.4, 25.8, 25.7, 18.0, -4.4 -4.9; 33b: TLC (40% EtOAc in hexane), R/i 0.65 (UV, CAM).
NDMB
OTBS
NDMB
HN
OTBS
To product a mixture of 34a and 34b (36 mg, 0.071 mmol) in AcOH was added KI (3
equiv.) and stirred at 100 °C for 1.5 hr. The reaction was diluted with water (15 mL)
85
and Na2CC>3 (10%, 10 mL) and extracted with EtOAc (3x10 mL). The organic layer was 
washed with NaHC03 with thiosulfate (10 mL), brine (10 mL), dried with Na2S04 , and 
concentrated in vacuo to afford a tan powder (32 mg, 91% yield).
4-allyl-5-((/er/-butyldimethylsilyl)oxy)-2-(2,4-dimethoxybenzyl)-2,5,6,7-tetrahydro- 
l//-cyclopenta[c]pyridin-l-one (35): Following general procedure C, using lactam 34 
(32 mg, 0.064 mmol) the intermediate acylated product was produced (34 mg, 0.063 
mmol, 98% yield). This intermediate product was used to produce the desired acetylated 
product following general procedure D. The product was purified by flash column 
chromatography on silica gel (elution:) to afford the product 36 (17 mg, 0.037 mmol, 
59% yield) as a yellow oi l : TLC (5% MeOH in chloroform), R/i 0.6 (UV, CAM).
NDMB
O
NDMB
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